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Abstract 
 Low-level Pb exposure is a risk factor for neurobehavioral and cognitive deficits 
in both humans and animals.  These neurological dysfunctions have been associated with 
deficits in auditory temporal processing.  The developing central nervous system is 
particularly susceptible to Pb exposure, and Pb decreases the immunoreactivity of 
serotonin (5-HT) and VMAT2 in the lateral superior olive (LSO).  During early 
developmental, “non-serotonergic” sensory neurons, including LSO neurons and 
thalamocortical neurons of the somatosensory system, transiently take up 5-HT from the 
extracellular environment through the transient expression of the serotonin reuptake 
transporter SERT.  Maintenance of appropriate 5-HT levels is important for development 
of these sensory systems.  The current study was undertaken to define the effect of 
developmental Pb exposure on the transient uptake of 5-HT in LSO and thalamocortical 
neurons and is the first of its kind.  CBA mice were exposed to 0 mM (control), 0.01 mM 
(very low), and 0.1mM (low) Pb acetate from gestation through postnatal day 4 (P4), P8, 
or P21.  Brainstem sections were immunostained for 5-HT, SERT, TPH, MAOA, 
VMAT2, SYP and GAP-43.  Total brainstem levels of 5-HT and its metabolite 5-
hydroxindole-3-acetic acid (5HIAA), were measured by HPLC.  We found that Pb 
extends the normal developmental uptake of 5-HT by LSO neurons through prolonged 
expression of SERT.  Total brainstem levels of 5-HT remain largely unchanged.  Pb also 
decreases VMAT2, SYP, and GAP-43 immunostaining within the P8 LSO, indicating 
that modulation of SERT by Pb leads to impaired maturation of synapses in the LSO.  
These effects persist into adulthood.  The major afferent target of the LSO, the Inferior 
Colliculus (IC), also shows altered immunoreactivity for 5-HT and VMAT2 following 
developmental Pb exposure.  Finally, Pb decreases the immunoreactivity of 5-HT at the 
thalamocortical axon terminals (TCAs) in the region of the somatosensory cortical barrel 
field.   In the forebrain, Pb appears to decrease 5-HT levels in general.  This differs from 
its effect in the brainstem where Pb appears to specifically target central auditory nuclei. 
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General Introduction  
Lead toxicity  
Lead (Pb) has long been recognized as a significant environmental pollutant with 
neurotoxic effects causing behavioral and cognitive deficits in humans (Finkelstein et al., 
1998; Canfield et al., 2003; Lanphear et al., 2005) and animals (Vazquez and Pena de 
Ortiz, 2004; Burger and Gochfeld, 2005).  Major environmental sources of Pb include 
Pb-based paints, food/drink cans, gasoline, and drinking water (Toscano and Guilarte, 
2005).  Pb-based paint, used between 1884 and 1978, is one of the major sources of Pb 
exposure in young children and accounts for exposure in 38 million living units in the 
United States in 2002 (Jacobs et al., 2003).  Drinking water can be contaminated by lead 
pipes and a recent study of the Washington, DC area by the CDC showed that about 18% 
of households in the DC area have Pb service pipes (Toscano and Guilarte, 2005).  
Canned food containing Pb solder was the major dietary source of Pb before 1995 
(Goyer, 1996).  Emmisions from the combustion of leaded fuels was a major source of 
atmospheric and soil Pb accumulation (Toscano and Guilarte, 2005). 
Regulatory initiatives limiting the lead content of paint and gasoline reduced the 
median blood Pb levels in children from 15 µg/dL in the late 1970s to 1.9 µg/dL in 2002 
(Bellinger, 2008).  The removal of Pb solder from canned foods have reduced the average 
dietry intake of Pb in a 2-year-old child from 30 µg/dL in 1982 to about 2 µg/dL in 1991 
in the United States (Toscano and Guilarte, 2005).  However, Pb still persists in the 
environment.  Pb paint and pipes remain in old residences and off-road vehicles, such as 
farm tractors, still use leaded gasoline.  In addition, Pb is found in toys with leaded paint, 
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cosmetics, folk medicines, glazed ceramics, bullets, and storage battery casings 
(Bellinger and Bellinger, 2006; Bellinger, 2008).   
The developing central nervous system (CNS) is particularly susceptible to 
environmental Pb exposure (Landrigan and Todd, 1994; Moreira et al., 2001), thus 
children are most vulnerable.  Currently, the Center for Disease Control (CDC) limit of 
concern for childhood blood Pb level remains at 10 µg/dL, and this level is thought to be 
a threshold for childhood cognitive deficits (Landrigan, 2000).  However, recent data 
suggests that detrimental effects of Pb on childhood cognition may be present at blood Pb 
levels lower than 10 µg/dL (Bellinger, 2008).  Children with blood Pb level of 5-10 
µg/dL have a 5.0 point total lower IQ score, with 7.8 points lower in reading scores, and 
6.9 points lower in math scores, compared to children with blood Pb levels of 1-2 µg/dL 
(Surkan et al., 2007).  Lanphear et al. reported that in children with blood Pb levels lower 
than 5 µg/dL, every 1 µg/dL increase of blood Pb concentration results in a 0.7 point 
decrease of mean arithmetic scores, an approximate one point decrease in mean reading 
scores, a 0.1 point decrease in nonverbal reasoning scores, and a 0.5 point decrease of 
short-term memory scores (Lanphear et al., 2000).  In addition, not only do the studies 
suggest the existence of adverse effect of Pb below 10 µg/dL, but also that the rate of 
decline in IQ scores may be greater at blood Pb levels below 10 µg/dL than at levels 
above 10 µg/dL (Bellinger and Bellinger, 2006).  Canfields et al. reported that in the 
children whose maximal blood Pb levels remain lower than 10 µg/dL, an increase of 
blood Pb level from 1 to 10 µg/dL results in an IQ decline of 7.4 points, whereas each 
increase of 10 µg/dL in the lifetime blood Pb level is associated with a 4.6 point decrease 
in IQ (Canfield et al., 2003).   
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Pb is also a risk factor for neurobehavioral deficits in children (Bellinger and 
Bellinger, 2006).  For example, a recent study found that children with blood levels 
greater than 2.0 µg/dL are at a 4.1-fold increased risk for attention deficit hyperactivity 
disorder (ADHD), and the authors conclude that approximately 290,000 cases of ADHD 
among U.S. children 4–15 years old can be attributed to environmental Pb exposure 
(Braun et al., 2006).  Aggression, explosive temper, and antisocial behavior related with 
crime rate have also been shown to be related to childhood Pb exposure (Nevin, 2007).  
According to the estimation by the US EPA in 2001, a reduction in a single IQ 
point results in an added financial burden of $8,346 dollars per Pb exposed child 
(Toscano and Guilarte, 2005).  Grosse et al. reported that the economic benefits of the IQ 
gain resulting from the substantial reduction in children’s blood Pb levels between 1976 
and 1999 is $110 to $319 billion dollars for each year’s cohort of 2-year-old children 
(Grosse et al., 2002).   
In spite of the extensive documentation of the toxic effects of Pb on cognitive 
and neurobehavioral functions, the underlying mechanisms by which Pb exerts its effect 
on the central nervous system, especially during development, has yet to be defined.   
Several studies suggest that exposure to Pb during gestation and the early postnatal 
period produces greater deficits in learning performances than Pb exposure in older 
animals (Jett et al., 1997; Kuhlmann et al., 1997).  Thus, there seems to be a critical 
period of brain development in which neuronal processes are highly vulnerable to the 
presence of Pb, leading to cognitive and behavioral abnormalities (Toscano and Guilarte, 
2005).  In general, Pb has been implicated in diverse processes such as mitochondrial 
dysfunction, oxidative stress, decreased cellular energy metabolism, altered regulation of 
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gene transcription, and alterations in neurotransmitter systems (Toscano and Guilarte, 
2005; Bellinger and Bellinger, 2006). 
 
Lead and auditory temporal processing 
Compared to the intensive studies conducted on the effect of developmental Pb 
exposure on cognitive disorders, little effort has been made to understand the impact of 
Pb exposure on sensory systems, including auditory and visual processing.  For example, 
auditory processing is vital for speech perception, especially in difficult listening 
situations when auditory signals can be masked due to background noise.  Subtle 
impairments of auditory processing by Pb exposure could therefore have profound long 
term effects on learning and memory (Otto and Fox, 1993).  In fact, Pb exposure is a risk 
factor for dyslexia (Glotzer et al., 1995) and ADHD (Braun et al., 2006), and children 
with either dyslexia or ADHD have deficits in auditory temporal processing, including 
backward masking (Breier et al., 2003; Facoetti et al., 2003; Putter-Katz et al., 2005; 
Wright and Conlon, 2009) and amplitude modulation detection (McAnally and Stein, 
1997). 
It is important to note that Pb appears to affect auditory temporal processing in 
the central auditory system, rather than producing sensorineural hearing loss at peripheral 
sites, including the cochlea and spiral ganglion (Otto and Fox, 1993).  Children who are 
exposed to Pb show altered auditory processing and a decreased performance in tests 
requiring appropriate timed reactions (Finkelstein et al., 1998).  An electrophysiological 
study in asymptomatic Pb-exposed children also shows increased latencies in the auditory 
brainstem response (ABR) in waves III and V and the interpeaks I-III and I-V (Holdstein 
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et al., 1986).  Impaired central auditory processing by Pb exposure is also found in animal 
models.  Our lab has demonstrated that Pb exposure in mice during development results 
in increased latencies in the ABR as measured in the interpeak interval between peaks I-
V as well as impaired temporal processing within the inferior colliculus (IC) (Jones et al., 
2008).   
The cellular mechanism that underlies Pb-induced auditory temporal processing 
deficits is largely unknown.  In 1999, Gray and Holian developed an avian model, in 
which Pb exposure during development results in deficits in auditory temporal 
processing, including backward masking (Gray et al., 1999).  Using this avian model, our 
lab demonstrated that Pb exposure produces a significant decrease in the amount of 
medium weight neurofilament (NFM) protein as well as decreases in the NFM 
phosphorylation in the axons connecting auditory nuclei in the brainstem (Lurie et al., 
2006).  Changes in the neurofilament protein were also observed in a mouse model.  In 
mice exposed to Pb during development, Pb results in increased phosphorylation of both 
the medium and high weight neurofilament within the auditory brainstem nuclei (Jones et 
al., 2008).  Neuritic beading in the axons within auditory region of the brainstem also 
increases with Pb exposure, suggesting that Pb could affect axonal transport, and possibly 
impairing synaptic transmission of neural signals in respond to sound (Jones et al., 2008).  
This in turn, might affect auditory temporal processing. 
 
Serotonin and auditory temporal processing   
While the physiological basis of auditory temporal processing has yet to be fully 
elucidated, serotonin (5-HT), as a neuromodulator, has been shown to modify responses 
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to sensory stimuli, rather than to elicit neural firing directly.   Especially in the IC, a 
midbrain auditory nucleus, 5-HT has been shown to preferentially facilitate or depress the 
response of some IC neurons to certain sounds, ranging from simple tone bursts to 
complex-species specific vocalizations, thus altering both the magnitude and latency of 
neural responses (Hurley and Pollak, 1999; Hurley et al., 2002; Hurley and Pollak, 2005a, 
b).  For example, ionophoretic application of 5-HT in the IC of Mexican free-tailed bats 
results in altered first-spike latencies and spike counts, depending on the type of neuron 
within the IC (Hurley and Pollak, 2005a).  In this study, 5-HT has been shown to create a 
unique spatiotemporal pattern of activity among neurons within the IC in response to 
specific vocalizations (Hurley and Pollak, 2005a).  5-HT also has been shown to play a 
neuromodulatory role in the in the dorsal and posteroventral cochlear nucleus, in that 
application of 5-HT to cochlear neurons inhibit acoustically evoked neuronal firing, 
indicating that 5-HT could be used to control background noise (Cransac et al., 1998).  
Thus, 5-HT plays a key role in modulating auditory temporal processing. 
Because previous studies have demonstrated that Pb induces auditory temporal 
processing deficits, it is possible that Pb alters the serotonergic system within central 
auditory nuclei, thereby affecting auditory temporal processing.  In support of this 
hypothesis, our lab has found that developmental Pb exposure results in decreased levels 
of 5-HT and norepinephrine (NE), and decreased expression of VMAT2 in brainstem 
auditory nuclei, especially in the lateral superior olive (LSO) (Fortune and Lurie, 2009). 
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Serotonergic innervation in the central auditory system 
Serotonin (5-HT) and its receptors are present in the auditory brainstem and 
midbrain nuclei, including the superior olivary complex (SOC), cochlear nucleus (CN) 
and the inferior colliculus (IC) (Thompson et al., 1994; Behrens et al., 2002; Hurley et 
al., 2002; Thompson and Hurley, 2004; Hurley et al., 2008).  While most of the 
serotonergic neurons innervating the IC and CN originate in the dorsal and, to a lesser 
extent, the median raphe nuclei (Klepper and Herbert, 1991; Thompson et al., 1991; 
Thompson et al., 1994), the origin of the 5-HT fibers in LSO has not been fully defined.  
It is likely that there is more than one source of serotonergic afferents to the SOC 
(Harvey et al., 1993), and dorsal and median raphe nuclei are not the major source of the 
serotonin found in the SOC (Thompson and Thompson, 2001).  
Various serotonin receptors are present in the SOC, CN, and IC (Harvey et al., 1993; 
Thompson et al., 1994; Thompson et al., 1995).  Immunohistochemical studies reveal that 
5-HT1A and 5-HT2B receptors are localized in the CN (Thompson et al., 1994; Tadros et 
al., 2007).  In the IC, seven main families of 5-HT receptor have been detected using 
techniques including radioligand binding, immunohistochemistry, and in situ 
hybridization (e.g., 5-HT1: (Thompson et al., 1994; Peruzzi and Dut, 2004); 5-HT2: 
(Cornea-Hebert et al., 1999); 5-HT3: (Morales et al., 1998); 5-HT4: (Vilaro et al., 2005); 
5-HT7: (To et al., 1995; Heidmann et al., 1998).  Several reports have suggested that 
members of the 5-HT1 receptor family are especially strongly represented, with a 
radioligand binding study indicating enrichment of the 5-HT1A receptor in the IC 
(Thompson et al., 1994).  An immunohistochemical study further suggested that 5-HT1A 
and 1B receptors are present on many IC neurons (Peruzzi and Dut, 2004).  Iontophoretic 
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application of the 5-HT1A receptor agonist, 8-OH-DPAT, results in either increased or 
altered spike counts, as well as changes in the spike temporal pattern as measured by first 
spike latency in the IC (Hurley and Pollak, 2005a; Hurley, 2006).  In the LSO, 5-HT1 and 
5-HT2 receptors are involved in the modulation of LSO synapses by inducing evoked 
excitatory postsynaptic currents (EPSCs) and depressing inhibitory postsynaptic currents 
(IPSCs) (Fitzgerald and Sanes, 1999).  
 
Serotonin in the developing central auditory system 
Serotonin (5-HT) has also been implicated in the development of two auditory 
nuclei, the anteroventral cochlear nucleus (AVCN), which is a part of the cochlear 
nuclear complex, and the lateral superior olive (LSO), which is a part of the superior 
olivary complex (SOC) (Cases et al., 1998).  The AVCN provides a major afferent input 
to the ipsilateral LSO, and the LSO, in turn, provides afferents to the inferior colliculus 
(IC) (Figure 1, (Thompson and Schofield, 2000; von Gersdorff and Borst, 2002).   
In MAOA knockout mice with abnormally high levels of 5-HT, almost all the cell 
bodies in LSO contain 5-HT immunostaining starting from embryonic day 18 (E18), and 
reaching maximal expression at birth (P0) to postnatal day 7 (P7).  This 5-HT 
immunoreactivity then disappears by P10 (Cases et al., 1998).  5-HT immunoreactive 
LSO neurons are also present in wild type mice examined at P1 and P8 (Thompson, 
2006).  LSO ascending neurons use glycine and glutamate as a neurotransmitter and thus 
are not considered being intrinsic serotonergic neurons (Thompson and Schofield, 2000).   
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Figure 1. Diagram of the auditory brainstem.  Auditory signals arriving at the cochlea 
are transmitted to the ipsilateral anterior ventral cochlear nucleus (AVCN).  The AVCN 
then provides a major afferent input to the ipsilateral lateral superior olive (LSO), and the 
LSO, in turn, provides afferents to the inferior colliculus (IC).  The LSO is a part of the 
superior olivary complex (SOC) that is composed of the medial nucleus of the trapezoid 
body (MNTB) and the medial superior olive (MSO) in addition to the LSO.	   
 
 
 
 
 
 
IC 
Modified	  from	  (Gersdorff and Borst, 2002) 
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Developing LSO neurons do not have the capability of synthesizing 5-HT, as 
evidenced by a lack of immunoreactivity for the 5-HT synthesizing enzymes, tryptophan 
hydroxylase (TPH) (Thompson, 2008) and L-amino acid decarboxylase (AADC) (Cases 
et al., 1998).  Instead, it is thought that these LSO neurons take up extracellular 5-HT 
through the 5-HT transporter (SERT) (Thompson and Thompson, 2009b).  In MAOA k/o 
mice, 5-HT and 5-HTT staining is co-localized in LSO neurons at P0 and P5-6, and all 
staining for both proteins disappears by P15 (Thompson and Thompson, 2009b).   
 Transient expression of 5-HT during peri and postnatal development in LSO 
neurons is proposed to have two functional applications.  First, 5-HT may be involved in 
the maturation of synapses within the LSO.  During postnatal development, the transient 
expression of 5-HT precedes the auditory inputs from cochlear nucleus and is 
concomitant to the maturation of synapses and dendrites in the LSO.  For example, the 
mature pattern of collateral branching of the afferents from the cochlear nucleus is 
established in the LSO during the period of E18 to P5 in rats (Kandler and Friauf, 1993; 
Friauf et al., 1999).  In rats, the refinement and pruning of dendrites of LSO neurons 
begins at P4 and is most dramatic after P14, which is shortly after the onset of hearing 
(around P12; (Rietzel and Friauf, 1998).  Furthermore, the expression of growth associate 
protein (GAP-43), a marker for axonal elongation and maturation of presynaptic endings, 
is strongly expressed starting from P1 in rats.  By P8, GAP-43 staining becomes 
restricted to the neuropil (Horvath et al., 1997) indicating more mature synapses.  In 
agreement with the GAP-43 data, 5-HT application activates prolonged bursts of 
spontaneous inhibitory postsynaptic currents (IPSCs) in young animals but this effect is 
not observed after P8 within slice preparations of gerbil LSO neurons (Fitzgerald and 
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Sanes, 1999).  Amplifying inhibitory transmission of the LSO in the first postnatal week 
prevents the normal developmental refinement of LSO dendrites and MNTB terminal 
arborizations (Sanes and Chokshi, 1992; Sanes et al., 1992; Sanes and Hafidi, 1996).  
Thus, 5-HT in the early postnatal period may play a developmental role by increasing 
IPSCs in the LSO.    
5-HT may also be involved in the development of the axonal projection from the 
LSO to its target area, which includes the lateral lemniscus (LL) and the central nucleus 
of the IC (CNIC) (Oliver, 2000).  Transient uptake of 5-HT in non-serotonergic neurons 
has been shown to be necessary for the precise arrangement and refinement of afferent 
sensory connections in the thalamocortical and retinothalamic projection neurons (Gaspar 
et al., 2003; Luo et al., 2003).  Alterations in brain 5-HT levels, either increases or 
decreases, during development disrupt the normal development of the tonographic 
sensory map in the somatosensory cortex, superior colliculus, and the dorsal lateral 
geniculate body (Gaspar et al., 2003).  Within the auditory system, Thompson and 
Thompson have recently reported that 5-HT immunoreactive LSO neurons in MAOA k/o 
mice do project to the CNIC (Thompson and Thompson, 2009a), further supporting the 
role of 5-HT in the proper topographic projection and terminal arborization of LSO 
neurons within the IC.  In the rat IC, developmental processes that include axon 
collateralization and synapse formation occur predominately from birth to P11 (Kandler 
and Friauf, 1993) and a marker for mature synapses, chondroitin sulfate proteoglycan, 
has been observed in the IC beginning at P8 (Friauf, 2000).  Thus, the transient 
expression of 5-HT in the LSO seems to play a developmental role in the IC by affecting 
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the collateral branching of axons originating from the LSO as well as the formation of 
functional synapses. 
 
Lead and serotonin 
 Environmental lead (Pb) adversely affects a variety of neurotransmitter systems, 
and the developing nervous system seems to be particularly susceptible to Pb exposure 
(Antonio et al., 2002; Leret et al., 2002; Devi et al., 2005).  Neurotransmitters, such as 5-
HT, are used as developmental signals, thus alterations in neurotransmitter systems 
during development can affect the construction and plasticity of brain circuits (Gaspar et 
al., 2003).  Among the neurotransmitter systems, serotonergic neurons are one of the 
earliest neurons to be generated in the brain and have been involved in a variety of 
developmental processes, including neurogenesis, programmed cell death, cell migration, 
dendrite and axonal development, synaptogenesis and synaptic plasticity (Luo et al., 
2003).   
Indeed, developmental Pb exposure has been shown to alter brain levels of 5-HT 
and a major metabolite of 5-HT, 5-hydroxytryopatamine (5-HIAA), in various brain 
regions (Cupo and Donaldson, 1988; Antonio et al., 1996; Antonio et al., 2002; Devi et 
al., 2005).  Mice exposed to 5mM and 25mM Pb-acetate from P1 through P21 show an 
increase in 5-HT with 0.2% (5mM) of Pb exposure and a decrease with 1% (25mM) of 
Pb exposure in all brain regions examined, including cerebral cortex, hippocampus, 
cerebellum, and medulla (Devi et al., 2005).  Developmental Pb exposure also alters 
MAO activity in the mouse and rat brain (Devi et al., 2005).  When rats are exposed to 
Pb-Ac (300 mg/L) from gestation through P5, both 5-HT and 5-HIAA levels decrease, 
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and increases in 5-HT turnover (5-HIAA/5-HT) are observed in the entire brain (Antonio 
et al., 1996).  When the same concentration of Pb-Ac (300 mg/L) is used to expose rats 
for a longer period (from gestation through P12), Pb exposure decreases 5-HT and 5-
HIAA in the hippocampus, and decreases 5-HT without affecting 5-HIAA levels in the 
hypothalamus and cerebellum (Antonio et al., 2002).  Similarly, Pb exposure from 
gestation through P28 results in decreases of 5-HT and 5-HIAA levels in the brainstem 
(Widmer et al., 1991).  Pb also increases 5-HT turnover with decreased 5-HT levels and 
increased 5-HIAA levels in the developing chick brain (Cupo and Donaldson, 1988).   
Thus, it is not surprising that we have found that very low level Pb exposure (10µM and 
100µM) during development (from gestation through P21) decreases immunoreactivity 
for both 5-HT and the vesicular monoamine transporter (VMAT2) in the lateral superior 
olive of mice (Fortune and Lurie, 2009). 
 
Serotonin and development of somatosensory barrel fields 
 In addition to central auditory neurons (including neurons in LSO and AVCN) 
several other sensory neurons also transiently express serotonin during development.  
These neurons include the thalamocortical neurons that project to the layer IV of 
somatosensory cortex where they form a distinct barrel-field pattern (Cases et al., 1998).  
In the mouse, each of the barrels corresponds to the afferent thalamic axonal projection 
from one whisker to the somatosensory cortex (Gaspar et al., 2003).  This organization 
emerges over the first postnatal week by axon collateral remodeling (Rebsam et al., 
2002). 
14 
 
 The transient uptake of 5-HT by thalamocortical neurons occurs through the 
transient expression of SERT and VMAT2 on the same neurons.  SERT is required for 
the uptake of 5-HT that is released or leaked out of neighbouring serotonergic processes 
originating from the raphe, and VMAT2 is required for the vesicular storage of 5-HT 
(Lebrand et al., 1996; Lebrand et al., 1998).  Similar to the LSO neurons, these thalamic 
neurons do not synthesize 5-HT, as evidenced by a lack of TPH and AADC (Cases et al., 
1998).  Vitalis et al, 2002 has demonstrated that MAOA is not expressed in the 
thalamocortical neurons, suggesting that the 5-HT taken up by thalamocortical neurons is 
not degraded and could be immediately stored into synaptic vesicles by VMAT2 (Vitalis 
et al., 2002). 
 Transient uptake of 5-HT by thalamocortical neurons is proposed to have two 
functional applications.  One hypothesis is that 5-HT could be used as a borrowed 
neurotransmitter, as these neurons express both SERT and VMAT2 (Vitalis et al., 2002).  
However, there is no direct evidence to date showing the actual release of 5-HT from 
these neurons. 
 Transient uptake of 5-HT is also a way to clear 5-HT away from the extracellular 
space during a critical period of somatosensory cortical barrel field development (Gaspar 
et al., 2003).  In fact, evidence suggests that precise regulation of 5-HT levels during 
development is very important for the proper formation of cortical barrel fields.  For 
example, in MAO k/o mice, where brain 5-HT levels are 6-9 fold higher than wild type 
mice during the first postnatal weeks, barrels are not formed, as the clustering of both the 
thalamocortical axons and the cortical granular neurons around thalamocortical axon 
endings are disrupted (Cases et al., 1996; Lebrand et al., 1996; Vitalis et al., 1998; Upton 
15 
 
et al., 1999).  Similar observations are found in SERT k/o mice, in which 5-HT continues 
to be released but cannot be removed from the synaptic cleft (Persico et al., 2001).  An 
excessive amount of 5-HT in the extracellular space is proposed to activate the 5-HT1B 
receptor, which is also transiently expressed presynaptically on thalamocortical axon 
terminals (Mooney et al., 1994; Laurent et al., 2002).  In double knock-out mice of 
MAOA/5HT1B receptor or SERT/5HT1B receptor, barrels are formed normally, despite 
elevated brain 5-HT levels (Salichon et al., 2001). 
 In contrast to the complete loss of barrel fields induced by excessive amounts of 
5-HT, depletion of 5-HT by pharmacological intervention results in barrel fields that are 
either smaller in size or are developmentally delayed (Turlejski et al., 1997; Persico et al., 
2001).  Indeed, depletion of 5-HT results in an overall delay of brain development, as 
evidenced by reduced brain and body weights (Persico et al., 2001).  Thus, the subtle 
effect of 5-HT depletion on barrel field formation may be the result of a 5-HT induced 
delay in general brain development, rather than a direct effect of 5-HT on cortical barrel 
field formation itself (Persico et al., 2001; Gaspar et al., 2003; Luo et al., 2003). 
 Taken together, the transient uptake of 5-HT by non-serotonergic thalamocortical 
neurons and precise regulation of 5-HT levels in this system are important for the 
formation of somatosensory cortical barrel fields.  Interestingly, Pb exposure has been 
shown to disrupt the development of the somatosensory barrel field cortex in rats (Wilson 
et al., 2000).  In rats exposed to Pb from P1 through P10, the total area of the barrel field 
in primary somatosensory cortex decreases with increasing doses of Pb (Wilson et al., 
2000).  Pb exposure, especially during early development, has a persistent detrimental 
effect on cognitive and behavioral decline in humans and animals (Needleman et al., 
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1990; Bellinger and Bellinger, 2006; Bellinger, 2008).  Thus, the Pb induced deficits in 
the development of the barrel field cortex in rodents may be indicative of the cognitive 
and behavioral impairments induced by Pb exposure during human development. 
 
General Hypothesis 
 The overall hypothesis for the current study is that Pb alters the normal transient 
uptake of serotonin (5-HT) by sensory neurons, including central auditory and 
thalamocortical neurons, leading to impaired axonal/dendritic arborization and synapse 
formation in these systems, and these changes persist in adult animal.  The current studies 
are the first to examine the effect of Pb on the transient expression of 5-HT in central 
auditory and thalamocortical neurons during development. 
 
The following Specific Aims are designed to test the hypothesis that Pb alters the 
normal transient uptake of 5-HT by sensory neurons, leading to permanent changes in 
axonal/dendritic arborization and synapse formation. 
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Specific Aims 
Specific Aim I:  Determine whether Pb alters the normal transient uptake of 5-HT by 
LSO neurons during the first postnatal week. 
- Does Pb alter the normal transient uptake of 5-HT by LSO neurons 
through modulating SERT expression?  
- Is the metabolism of 5-HT (Synthesis, degradation, re-uptake of 5-
HT) changed with Pb exposure?  
- What are the outcomes of the Pb-induced alterations in the transient 
uptake of 5-HT by the LSO neurons?  
 Is Axonal/dendritic arborization and synaptogenesis modified 
in the Pb-exposed LSO  
Specific Aim II:  Characterize whether developmental Pb exposure has a permanent 
effect on the serotonergic innervation in the LSO and IC of adult mice. 
-  Define the mechanism underlying the Pb-induced decreases in 5-HT 
positive processes in the adult LSO. 
 Acute (synthesis, degradation, or re-uptake of 5-HT) vs. 
Developmental effect 
- Does Pb alter 5-HT expression in the adult IC, and if so, what is the 
mechanism? 
 Acute (synthesis, degradation, or re-uptake of 5-HT) vs. 
Developmental effect 
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Specific Aim III:  Determine the effect of developmental Pb exposure on the transient 
uptake of 5-HT by thalamocortical neurons at their axon terminals in early postnatal 
mice.   
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CHAPTER I. 
LOW LEVELS OF Pb EXPOSURE RESULTS IN DELAYS IN THE NORMAL 
TRANSIENT UPTAKE OF 5-HT BY LSO NEURONS THROUGH PROLONGED 
EXPRESSION OF SERT 
 
Abstract  
Low-level Pb exposure has been associated with neurobehavioral and cognitive 
deficits in children, and also has been shown to alter auditory temporal processing in both 
humans and animals.  We have previously reported that developmental Pb exposure 
decreases  immunoreactivity for serotonin (5-HT) and the vesicular monoamine 
transporter 2 (VMAT2) in the lateral superior olive (LSO) of P21 mouse.  During early 
peri and postnatal development, certain “non-serotonergic” sensory neurons, including 
LSO neurons, transiently take up 5-HT from the extracellular environment through 
transient expression of the serotonin reuptake transporter (SERT), and maintaining proper 
5-HT levels is important for the development of these sensory systems.  The current 
study was designed to define the effect of developmental Pb exposure on the serotonergic 
system in the LSO of the early postnatal mouse.  Mice were exposed to very low Pb 
(0.01mM) or low Pb (0.1mM) throughout gestation and postnatal day 4 (P4) and P8.  
Brainstem sections from control and Pb exposed mice were immunostainined for 5-HT, 
SERT, tryptophan hydroxylase (TPH), monoamine oxidase A (MAO-A), and VMAT2.  
Total brainstem levels of 5-HT and its metabolite, 5-hydroxindole-3-acetic acid (5HIAA), 
were also measured by HPLC analysis.  To test whether Pb exposure affects the synapse 
formation of LSO, brainstem sections were immunostained for synaptophysin (SYP) and 
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GAP-43.  Pb exposure delays and extends the normal developmental uptake of 5-HT by 
LSO neurons through prolonged expression of SERT.  This effect of Pb targets the 
transient uptake of 5-HT by LSO neurons through altered expression of SERT.   Pb does 
not alter synthesis or degradation of 5-HT within the entire brainstem.  Pb decreases 
VMAT2, SYP, and GAP-43 immunostaining within the LSO, indicating that the 
extended developmental uptake of 5-HT by LSO neurons is correlated with impaired 
maturation of synapses in the LSO.  Finally, Pb decreases total brainstem levels of DA 
and the major metabolites of DA, 3,4-dihydroxyphenylacetic acid (DOPAC).  This 
indicates that Pb may also affect the dopaminergic neurotransmitter systems within the 
developing brainstem.   
 
Introduction 
Lead (Pb) is a widespread environmental pollutant with neurotoxic effects causing 
neurobehavioral and cognitive deficits in humans (Finkelstein et al., 1998; Canfield et al., 
2003; Lanphear et al., 2005).  The developing central nervous system (CNS) is 
particularly susceptible to environmental Pb exposure (Landrigan and Todd, 1994; 
Moreira et al., 2001), suggesting that Pb may alter critical stages of development.  
Currently, the Centers for Disease Control (CDC) limit of concern for childhood blood 
Pb level remains at 10 µg/dL, and this level is thought to be a threshold for childhood 
cognitive deficits (Lanphear et al., 2000).  However, recent data suggests that blood Pb 
levels lower than 10 µg/dL produce cognitive and neurobehavioral disorders such as 
attention deficit hyperactivity disorder (ADHD), and dyslexia (Glotzer et al., 1995; 
Lanphear et al., 2000; Bellinger and Bellinger, 2006; Braun et al., 2006; Bellinger, 2008).  
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Pb exposure is also associated with deficits in central auditory temporal processing 
(Finkelstein et al., 1998; Lurie et al., 2006; Jones et al., 2008), and children with either 
dyslexia or ADHD have been shown to have deficits in auditory temporal processing 
(Breier et al., 2003; Facoetti et al., 2003; Putter-Katz et al., 2005; Wright and Conlon, 
2009). 
The cellular mechanism that underlies these Pb-induced cognitive and 
neurobehavioral dysfunctions are largely unknown.  We have previously reported that 
low-level Pb exposure during development decreases  serotonin (5-HT) and vesicular 
monoamine transporter 2 (VMAT2) immunostaining in brainstem auditory nuclei, 
particularly in the lateral superior olive (LSO) (Fortune and Lurie, 2009).   5-HT has been 
implicated in the modulation of auditory temporal processing by altering multiple aspects 
of neural responses to sound, ranging from simple tone bursts to complex-species specific 
vocalizations (Hurley et al., 2002; Hurley and Pollak, 2005).  However, the role of 5-HT 
during central auditory development has not been fully elucidated.   
During development of the brain, certain “non-serotonergic” neurons transiently 
express 5-HT.  These neurons include the principle projection neurons of sensory systems 
such as the auditory, visual, and somatosensory systems (Gaspar et al., 2003).  These 
neurons cannot synthesize 5-HT, as evidenced by lack of the 5-HT synthesizing enzymes 
tryptophan hydroxylase (TPH) and L-aromatic acid decarboxylase (AADC).  Instead, 
they accumulate 5-HT through uptake by SERT, a high affinity 5-HT transporter, which 
is also transiently expressed in these same neurons (Gaspar et al., 2003; Thompson, 
2008).  In the auditory system, a subset of LSO neurons transiently express 5-HT from 
postnatal day 1 (P1) to P8 in wild-type mice, and from embryonic day 18 to P10 in 
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Monoamine Oxidase A (MAOA) knockout mice (Cases et al., 1998; Thompson, 2006).  
Alterations in 5-HT homeostasis during development have been shown to cause 
permanent changes to adult behavior and to modify the fine wiring of neural connections 
in the brain (Gaspar et al., 2003).  For example, in thalamocortical neurons, precise 
regulation of 5-HT levels is important for the formation of somatosensory cortical barrel 
fields (Gaspar et al., 2003; Luo et al., 2003).  Interestingly, Pb exposure has been shown 
to disrupt the development of the somatosensory barrel field cortex in rats (Wilson et al., 
2000).  However, the effect of Pb exposure on the transient uptake of 5-HT in auditory 
neurons has not been explored. 
The current study was undertaken to define the interactions between 
developmental Pb exposure and the serotonergic system in central auditory nuclei in early 
postnatal mice.  Brainstem sections from postnatal control and Pb-exposed mice were 
immunostained for 5-HT, SERT, TPH, MAO-A, and VMAT2.  Total brainstem levels of 
5-HT and its metabolite, 5-hydroxindole-3-acetic acid (5HIAA), were measured by 
HPLC analysis.  To test whether Pb exposure affects the development of LSO, especially 
synaptic maturation, brainstem sections were also immunostained for synaptophysin 
(SYP) and GAP-43.   
We found that immunoreactivity for 5-HT in LSO somata was less in Pb exposed 
mice at P4 compared to controls.  In contrast, LSO neurons in P8 control mice showed 
very little 5-HT immunoreactivity, but Pb exposed LSO neurons at P8 continued to be 
immunopositive for 5-HT.  These results indicate that Pb appears to delay, then extend, 
the normal developmental uptake of 5-HT by LSO neurons.  In agreement with these 
findings, immunoreactivity for SERT in LSO somata was decreased in Pb exposed mice 
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at P4 and increased at P8.  These SERT positive somata were co-localized with 5-HT, 
demonstrating that Pb appears to modulate SERT expression (and consequently 5-HT 
uptake) in LSO neurons.  We also confirmed that LSO neurons are immune-negative for 
TPH and MAOA.   In addition, total 5-HT levels and 5-HT turnover did not change with 
Pb exposure in the brainstem fraction of P4 mice.  Finally, Pb decreases 
immunoreactivity for VMAT2, SYP, and GAP-43, demonstrating that the Pb-induced 
disruption of 5-HT accumulation in LSO neurons is correlated with impaired synaptic 
maturation within the LSO.  
 
Materials and Methods 
Chronic lead exposure to CBA/CaJ mice 
 Breeding pairs of CBA/CaJ mice were obtained from the Jackson Laboratory (Bar 
Harbor, MA).  Mice were maintained in microisolator units and kept in the University of 
Montana specific pathogen free animal facility.  Cages, bedding, and food were sterilized 
by autoclaving and mice were handled with aseptic gloves.  Mice were allowed food and 
water ad libitum.  All animal use was in accordance with NIH and University of Montana 
IACUC guidelines.  Breeding pairs of CBA mice were randomly assigned to three groups 
having unlimited access to water (pH 3.0) containing 0 mM (control), 0.01 mM (very 
low) or 0.1 mM (low) lead acetate.  Offspring were exposed to lead throughout gestation 
and through the dam’s milk until sacrifice on postnatal day 4 (P4), or day 8 (P8).  These 
concentrations of Pb yield blood Pb levels of 8.0 ± 0.4 µg/dL in very low Pb, and 42.3 ± 
1.97 µg/dL in low Pb P21 mice (Fortune and Lurie, 2009).   
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Tissue preparation for Immunohistochemistry 
 Mice were deeply anesthetized using 2’,2’,2’-tribromoethanol (TBE) and perfused 
transcardially with 4% Na-periodate-lysine-paraformaldehyde fixative (PLP, final 
concentrations 0.01M sodium periodate, 0.075M lysine-HCl, 2.1% paraformaldehyde, 
0.037M phosphate).  Brains were removed and post-fixed in PLP overnight at 4°C, rinsed 
3 times for 10 minutes each in phosphate buffered saline (PBS) and transferred to a 20% 
sucrose solution in PBS for 2 days at 4°C.  Finally, brains were transferred to a 1:1 
mixture of a 20 % sucrose solution in PBS and Optimal Cutting Temperature (O.C.T.) 
compound (Sakura Finetek, Torrance, CA) for 1-2 days at 4°C.  Brains were embedded 
into 1.5 cm square embedding cups filled with O.C.T. compound, and then frozen in dry 
ice and 100% ethanol and stored at -20°C.  Ten micron tissue sections were cut on a 
Thermo Shandon Cryotome Cryostat (Thermo Shandon, Pittsburg, PA) and a one in three 
series was collected for each brain.    
 
Immunohistochemistry   
 Sections were thawed to room temperature and rinsed in PBS three times for 10 
minutes each.  Sections were then permeabilized for 30 minutes in 0.5% Triton X-100 in 
PBS and blocked for 30 minutes with 4% of the appropriate normal serum (normal goat 
serum, normal rabbit serum, normal chicken serum, normal sheep serum, normal donkey 
serum, Vector Laboratories, Burlingame, CA) in PAB (1% sodium azide, 0.5% bovine 
serum albumin in PBS) and incubated with primary antibody for 1-4 days in a humid 
chamber at 4°C.  The sections were rinsed in PBS three times for 10 minutes each and 
incubated with the appropriate secondary antibody, Alexa Fluor-488, 568, 594, 633; 
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1:400, or 488 Avidin-Biotin complex; 1:500 (Invitrogen, Grand Island, NY) in PAB for 1 
hour at room temperature in the dark.  Sections were then rinsed in PBS followed by 
distilled water and coverslipped with FluorSaverTM (Calbiochem®, San Diego, CA) and 
stored at 4°C.  The primary antibodies used for immunohistochemitry were as follows:  
rabbit polyclonal anti-5-HT (1:10,000); goat polyclonal anti-5-HT (1:500); rabbit 
polyclonal anti-VMAT2 (1:2000), rabbit polyclonal anti-SERT (1:250), sheep polyclonal 
anti-TPH (1:500), goat polyclonal anti MAOA (1:500); mouse monoclonal anti-
Synaptophysin (1:12,000); rabbit polyclonal anti-GAP43 (1:1000).   
 
Antibodies 
The rabbit polyclonal against serotonin (5-HT) was raised in rabbit against 
serotonin coupled to bovine serum albumin with paraformaldehyde (Cat. No. 20080, 
ImmunoStar Inc., Hudson, WI).  No cross-reactivity of serotonin antisera was seen with 
5-hydroxytrytophan, 5-hydroxyindole-3-acetic acid, and dopamine (manufacturer’s 
specifications).   This 5-HT antibody labels our mouse brainstem sections in a staining 
pattern virtually identical to that of other studies using the same antiserum to label the 
mouse superior olive and inferior colliculus (Hurley et al., 2002; Thompson, 2006) and 
has been previously well characterized in our system (Fortune and Lurie, 2009).  In 
addition, preadsorption with the 5-HT/bovine serum albumin (BSA) conjugate protein 
(20 µg/ml, Cat. No. 20081, ImmunoStar Inc., Hudson, WI) eliminates all 
immunoreactivity, whereas preadsorption with BSA does not affect immunostaining.   
 The goat polyclonal against serotonin (5-HT) was raised in goat against serotonin 
coupled to bovine serum albumin with paraformaldehyde (Cat. No. 20079, ImmunoStar 
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Inc., Hudson, WI).  No cross-reactivity of serotonin antisera was seen with 5-
hydroxytrytophan, 5-hydroxyindole-3-acetic acid, and dopamine (manufacturer’s 
specifications).  This 5-HT antibody labels our mouse brainstem sections in a staining 
pattern virtually identical to that of other studies using the same antiserum to label the 
mouse superior olive (Fortune and Lurie, 2009; Thompson and Thompson, 2009b, a).  In 
addition, preadsorption with the 5-HT/bovine serum albumin (BSA) conjugate protein 
(20 µg/ml, Cat. No. 20081, ImmunoStar Inc., Hudson, WI) eliminates all 
immunoreactivity, whereas preadsorption with BSA does not affect immunostaining.   
 The rabbit polyclonal antibody against serotonin transporter (SERT) was raised in 
rabbit against synthetic peptide sequence corresponding to amino acids (602-622) of rat 
5-HT transporter coupled to keyhole limper hemocyanin (Cat. No. 24330, ImmunoStar 
Inc., Hudson, WI).  This SERT antibody labels our mouse brainstem sections in a 
staining pattern virtually identical to that observed in mouse superior olive (Thompson 
and Thompson, 2009a). 
 The sheep polyclonal antibody against tryptophan hydroxylase (TPH) was raised 
in sheep against recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies 
from E.coli (Cat. No. AB1541, Millopore, Temecula, CA).  This TPH antibody labels our 
mouse brainstem sections in a staining pattern virtually identical to that observed in 
mouse superior olive and raphe nuclei (Thompson and Thompson, 2009a). 
The goat polyclonal anti MAOA was raised in goat against a peptide mapping 
near the C-terminus of MAO-A of human origin (Cat. No. sc-18396, Santa Cruz 
Biotechnology Inc., Santa Cruz, CA).  This MAOA antibody labels our mouse brainstem 
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sections in a staining pattern virtually identical to that observed in the rat locus coeruleus  
(Arai et al., 1997). 
The rabbit polyclonal antibody against vesicular monoamine transporter 2 
(VMAT2, C-terminal) was raised in rabbit against synthetic peptide comprising amino 
acids sequence (496-515) at the cytoplasmic C-terminus of rat VMAT2 (Cat. No. 
135402, Synaptic System, Gottingen, Germany).  This VMAT2 antibody labels our 
mouse brainstem sections in a staining pattern virtually identical to that observed in the 
rat median eminence (Erickson et al., 1996) and has been previously well characterized in 
our system (Fortune and Lurie, 2009). 
The mouse monoclonal antibody against synaptophysinwas raised against in the 
vesicular fraction of bovine brain against the SY38 epitope; a pentapeptide repeat 
structure in the C-terminal cytoplasmic tail of syanptophysin (Cat. No. MAB5258, 
Millopore, Temecula, CA).  This synaptophysin antibody labels our mouse brainstem 
sections in a staining pattern virtually identical to that observed in the ferret superior 
olive (Alvarado et al., 2004), and the rat superior olive (immunostained with a different 
mouse monoclonal antibody against synaptophysin (Sigma; Caminoset al., 2007)).  This 
antibody has also been characterized in our mouse system (Fortune and Lurie, 2009). 
The rabbit polyclonal anti-GAP43 was raised in rabbit against GAP-43 synthetic 
peptide sequence corresponding to amino acids (216-226) of rat GAP-43 (Cat. Ab7462, 
Abcam Inc., Cambridge, MA).  This GAP-43 antibody labels our mouse brainstem 
sections in a staining pattern virtually identical to that observed in the rat optic nerve 
(Lingor et al., 2007), and the rat superior olive immunostained with a different mouse 
monoclonal antibody against GAP-43 (Roche; (Horvath et al., 1997)). 
28 
 
Tissue Imaging and analysis 
All fluorescent slides were viewed at either a 40x or a 60x objective using either a 
Bio-Rad Radiance 2000 Confocal microscope or an Olympus FV 1000 Fluoview 
Confocal microscope.  Quantitative analysis for immunostaining was performed as 
previously described (Fortune and Lurie, 2009).  Briefly, images were collected and then 
converted from color tiff files to black and white 12-bit tiff files, and the integrated 
optical density (IOD) of the immunostaining was measured using MediaCybernetics 
Image-Pro software (Bethesda, MD).  IOD measurements were used for quantification of 
immunostaining because it analyzes both the area of immunostained tissue that met 
threshold as well as the intensity of the immunostaining.  A threshold of immunostaining 
in control (No Pb) animals was set for each antibody such that all immunoreactivity met 
threshold, and was used as a comparison with the Pb treatment groups.  Immunostaining 
within the LSO in control and Pb-exposed mice was then quantified and averaged.  To 
separately measure the IOD of 5-HT immunostaining in the LSO neuronal cell bodies 
and processes,, a threshold for object size was also set such that either only neuronal cell 
bodies or processes were selected for IOD measurement.  Statistical differences in 
immunostaining between control and Pb-exposed mice were analyzed using 
KaleidoGraph software (Synergy Software, Reading, PA) or GraphPad Prism 4.0 
software (GraphPad Software, La Jolla, CA). 
 
Sample preparation for HPLC analysis  
Brains from P4 mice were quickly dissected and the forebrain was removed with 
a coronal cut separating dorsally the superior and inferior colliculus.  After dissection, the 
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remaining basal cerebral cortex and cerebellum were gently removed from the separated 
brainstem fraction under the dissecting microscope.  The remaining brainstem fraction 
includes inferior colliculus, ventral and dorsal brainstem.  Brainstem fractions were 
immediately weighed, and quickly frozen in the liquid nitrogen.  Brainstem fractions 
from two mice were then combined, and homogenized in 500 µl of 0.05 M perchloric 
acid solution (PCA) (Branson Sonifier 150, Branson, Danbury, CT), and stored at -20 ºC 
until ready to use. 
 
RP-HPLC analysis of 5HT/5HIAA and DA/DOPAC/HVA 
 5-HT and its metabolite, 5-hydroxyindole-3-acetic acid (5-HIAA) levels were 
measured using reverse phase high performance liquid chromatography (RP-HPLC) with 
electrochemical detection.  The homogenates were centrifuged at 14,000 x g for 20 min at 
4ºC and the supernatants filtered through a Millex® hydrophilic LCR (PTFE) 0.45 um 
filter (Millipore, Bedford, MA).  Sample filtrates were loaded into autosampler vials and 
were placed into an ESA Model 5 autosampler (ESA, Chelmsford, MA).  An OmniSpher 
5 C18 chromatographic column (Varian Inc., Lake forest, CA) with a length of 25 cm and 
an internal diameter of 4.6 mm was used to separate analytes.  The mobile phase 
consisted of water:acetonitrile (9:1, vol/vol) containing 0.15 M monochloroacetic acid, 
0.12 M sodium hydroxide, 0.6 mM EDTA and 1.30 mM sodium octyl sulfate, and the pH 
was adjusted to 3.2 with glacial acetic acid.  A constant flow rate of 1ml/min was 
maintained and the column effluent was analyzed with a Model 5600A ESA CoulArray® 
electrochemical detector (ESA, Chelmsford, MA).  Potentials of the three ESA Model 
6210 four channel electrochemical cells, placed in series, were as follows: (channels 1 
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through 5)-50, 0, 25, 100, 200 mV, (6 through 12) 300 mV.  5-HIAA and 5-HT were 
monitored at 200 mV.  DA and DOPAC were monitored at 100 mV, and HVA was 
monitored at 300 MV.  Peak area ratios were used to calculate 5-HT and 5-HIAA levels 
from a calibration curve (peak area of analyte/ peak area of DBA).   
 
Statistical Analysis 
Data are expressed as mean ± SEM and were analyzed using a one-way analysis 
of variance (ANOVA) followed by Dunnett’s post hoc test; P < 0.05 was considered 
significant. 
 
Results  
Pb exposure alters the normal uptake of 5-HT by developing LSO neurons  
In order to determine whether developmental Pb exposure affects the normal 
uptake of 5-HT by LSO neurons in early postnatal ages, control and Pb-exposed 
brainstem sections from postnatal day (P) 4 and P8 were immunostained for 5-HT.  Many 
5-HT immuno-positive cell bodies were observed in the LSO of control mice at P4 
(Figure 2A).  Very low Pb exposure significantly decreased 5-HT immunoreactivity in 
the LSO somata (Figure 2B) compared with controls (Figure 2A).  Quantification of the 
immunostaining showed a 54% decrease in 5-HT staining within LSO cell bodies (Figure 
2D).  In contrast, low Pb exposure did not change 5-HT immunoreactivity in LSO 
neurons (Figure 2C, 2D).  5-HT immunoreactivity in the processes within the LSO was 
not altered in either the very low and low Pb exposed mice (Figure 2E), demonstrating 
that the effect of Pb exposure is restricted to the uptake of 5-HT by LSO neurons.     
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By P8, control LSO neurons have lost most of their immunoreactivity for 5-HT 
with very few LSO cell bodies demonstrating any 5-HT immunostaining (Figure 3A).  In 
contrast, in the Pb-exposed mice, 5-HT positive cell bodies continued to be observed in 
two out of the five mice in the very low Pb group (Figure 3B) and in five out of five mice 
in the low Pb group (Figure 3C).  Quantification of 5-HT staining in the LSO somata 
demonstrated the low Pb mice continued to express significant amounts 5-HT 
immunostaining at P8 (Figure 3D).  5-HT staining intensity in the processes within the 
LSO was not significantly changed in Pb exposed mice compared to control mice (Figure 
3E), once again confirming that the effect of Pb is on the uptake of 5-HT within neuronal 
cell bodies. 
Taken together, these findings demonstrate that Pb appears to delay the normal 
developmental uptake of 5-HT by LSO neurons.  Pb exposed LSO neurons contained less 
5-HT at P4 than controls, suggesting a delay in the onset of the ability to take up 5-HT.  
However, Pb-treated LSO neurons continued to express 5-HT at P8, a time when LSO 
neurons usually lose the ability to transport 5-HT into the cell body.  These results 
illustrate that Pb temporally shifts the ability of LSO neurons to transiently take up 5-HT.  
Our results also document that this effect of Pb is specific for the transient uptake of 5-
HT by LSO neurons, because Pb did not alter 5-HT immunostaining in processes within 
LSO.  These 5-HT positive processes are thought to represent the serotonergic 
innervation from the raphe (Thompson, 2006).  
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Figure 2.  5-HT immunofluorescence labeling (green) in the LSO somata and processes 
within the LSO of postnatal day (P) 4 mice.  A-C: Very low Pb (B) exposure decreases 5-
HT expression in the LSO somata (red arrows) compared to control mice (A).  Low Pb 
(C) does not result in significant changes in 5-HT expression.  Pb exposure (B, C) does 
not affect 5-HT expression levels in the processes (white arrows) within the LSO.  D: 
Quantification of 5-HT immunostaining in the LSO somata confirms a statistically 
significant decrease in very low Pb exposed mice.  E:  Pb has no effect on 5-HT 
immunostaining in LSO processes at P4.  Graphs represent mean ± SEM.  *p<0.05; 
ANOVA with Dunnett’s post hoc test (n = 6-8).  Scale bar = 15 µm. 
A B 
C D 
E 
*	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Figure 3.  5-HT immunofluorescence labeling (green) in the LSO somata and processes 
within the LSO of P8 mice.  A-C: Immunoreactivity for 5-HT in the LSO somata (red 
arrows) increases slightly in the very low (B) mice and shows a significant increase with 
low (C) Pb exposure compared to control mice (A).  Pb exposure (B, C) does not 
significantly affect 5-HT expression levels in the processes (white arrows) within the 
LSO.  D: Quantification of 5-HT immunostaining in the LSO somata confirms a 
statistically significant increase in low Pb mice.  E:  Pb does not have a significant effect 
on 5-HT immunostaining in LSO processes at P8.  Graphs represent mean ± SEM.  
*p<0.05; ANOVA with Dunnett’s post hoc test (n = 5).  Scale bar = 15 µm. 
*	  C D 
E 
A B 
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5-HT uptake into LSO neurons is correlated with SERT expression  
The literature has demonstrated that LSO neurons take up 5-HT transiently during 
development through the transient expression of SERT on LSO neuronal cell bodies.  
However, these previous studies were performed in MAO/ko mice with abnormally high 
levels of 5-HT.  To confirm that 5-HT positive LSO neurons in wild type mice also 
express SERT, brainstem sections from control and Pb exposed P4 and P8 mice were 
double immunostained for 5-HT and SERT. 
Somata as well as processes in the LSO were indeed double-labeled for both 5-
HT and SERT in P4 and P8 mice (Figure 4).  At P4, the Pb-induced decrease in 5-HT 
staining within LSO neurons (very low dose) was correlated with a loss of SERT 
immunoreactivity in these same cells (Figure 4A-C).  At P8, Pb-exposed LSO neurons 
continued to express 5-HT, and these neurons also expressed a considerable amount of 
SERT (Figure 4D-F).  Taken together, these results indicate that Pb appears to delay the 
normal developmental uptake of 5-HT through delayed expression of SERT in the LSO 
neurons.  
 It is important to note that the effect of Pb on SERT appears to be specific for 
SERT expression on LSO somata.  Total levels of SERT immunoreactivity within the 
LSO (which mostly represent SERT immunoreactivity localized in neuronal processes) 
did not change with Pb exposure (Figure 5).  This suggests that Pb specifically targets 
SERT expression on neuronal cell bodies.  Figure 5 also illustrates that the amount of 
SERT immunoreactivity almost doubled from P4 to P8.   
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Figure 4.  High magnification micrographs of LSO double-labeled for 5-HT (red) and 
SERT (green) in the LSO somata and processes in P4 and P8 mice.  A-C: At P4, very 
low (B) Pb exposure decreases co-localization of 5-HT and SERT (arrows) in the LSO 
compared to control (A).  Low (C) Pb exposure does not affect co-localization of 5-HT 
and SERT (arrows) and the staining is similar to controls.  D-F: At P8, very low (E) and 
low (F) Pb exposure increases co-localization of 5HT and SERT in LSO somata 
compared to control (arrows, D).  The boxed areas in D, E, F are enlarged in D’, E’, F’, to 
better illustrate the co-localization of 5-HT and SERT in the processes (D’) and LSO 
somata (E’, F’).   Scale bar = 30 µm in F (applied to A-F). 
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Figure 5.  Low magnification picture of the majority of LSO immunostained for SERT 
(green).  Pb does not result in significant changes in total SERT expression within LSO at 
either P4 (A-C) or P8 (D-F).  G;H:  Quantification of SERT immunostaining confirms 
that Pb does not affect total SERT immunoreactivity in the LSO.  However, the amount 
of SERT immunoreactivity almost doubles from P4 to P8.  Graphs represent mean ± 
SEM.  ANOVA with Dunnett’s post hoc test (n = 5).  Scale bar = 30 µm. 
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Confirmation that LSO neurons do not contain 5-HT metabolizing enzymes, 
including TPH and MAOA 
 To rule out the possibility that Pb induced alterations in 5-HT immunostaining in 
LSO neurons during early postnatal development is the result of changes in 5-HT 
synthesis and/or degradation, brainstem sections from control mice were immunostained 
for the 5-HT synthesizing enzyme, tryptophan hydroxylase (TPH).  LSO neurons have 
been found to be immuno-negative for TPH in P6 MAOA k/o mice (Thompson and 
Thompson, 2009a).  In agreement with these studies, LSO somata were immuno-negative 
for TPH in our P4 mice (Figure 6A).  As expected, neurons in the raphe located in the 
same brainstem section were strongly immuno-positive for TPH (Figure 6B).   
Within intrinsic serotononergic neurons, 5-HT that is taken up from the 
extracellular space by SERT is rapidly degraded by monoamine oxidase (MAOA) 
(Vitalis et al., 2002).  We tested whether the 5-HT-positive LSO neurons observed at P4 
also contain MAOA.  MAO activity has been shown to be modulated by Pb (Devi et al., 
2005) and therefore could be a potential mechanism by which Pb changes 5-HT levels in 
LSO neurons during postnatal development.  Double-labeling for 5-HT and MAOA in 
the LSO of P4 control mice demonstrated that 5-HT-positive LSO somata were immuno-
negative for MAOA (Figure 6C).  In contrast, adjacent raphe neurons were immune-
positive for both 5-HT and MAOA (Figure 6D).   
These results confirm that the Pb-induced changes in 5-HT immunostaining 
within LSO neurons are the result of modulation of SERT expression, because LSO 
neurons were immuno-negative for TPH and MAOA.  
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Figure 6.  LSO neurons of P4 mice do not express tryptophan hydroxylase (TPH) or 
monoamine oxidase-A (MAOA).  A, B: The LSO (A) does not contain any TPH (green) 
immuno-positive somata unlike neurons in the raphe pallidus (B) where there are many 
immunopositive neurons.  C, D:  Double immunolabeling of 5-HT (red) and MAOA 
(green) shows that the 5-HT positive neurons in the LSO (C) do not contain any MAOA 
immuno-positive somata, unlike neurons in the raphe pallidus where there is obvious 
double label (yellow) within many neurons (D).  Scale bar = 30 µm.   
41 
 
Pb exposure does not affect total 5-HT and 5HIAA levels in the brainstem  
 Although LSO neuronal cell bodies were immuno-negative for both TPH and 
MAOA, the possibility remains that Pb affects the synthesis or degradation of 5-HT 
within the entire brainstem.  Therefore levels of 5-HT and a major metabolite of 5-HT, 5-
hydroxyindole-3-acetic acid (5-HIAA), were measured in crude brainstem fractions 
(which contains all of the serotontergic raphe nuclei) of P4 mice by HPLC analysis.  Pb 
exposure did not result in significant changes in brainstem levels of 5-HT and 5HIAA 
compared to controls (Figure 7A, 7B).  5-HT turnover (5-HIAA/5-HT) was also not 
changed, suggesting that Pb does not affect degradation of 5-HT within the brainstem 
(Figure 7C).  These findings demonstrate that the Pb-induced changes in the transient 
accumulation of 5-HT by LSO neurons are not the result of changes in total brainstem 5-
HT levels.  This adds further support to our hypothesis that Pb alters the transient uptake 
of 5-HT by LSO neurons through changes in SERT expression. 
 
Pb exposure decreases immunoreactivity for the vesicular monoamine transporter 2 
(VMAT2) within the LSO 
 The monoamines including dopamine, serotonin, and norepinephrine are 
transported into synaptic vesicles by the vesicular monoamine transporter 2 (VMAT2).  
In addition to the intrinsic monoamine neurons, certain non-serotonergic neurons, such as 
sensory thalamic neurons that transiently take up 5-HT, have also been shown to express 
VMAT2 transiently in early postnatal ages, suggesting that the 5-HT taken up by these 
neurons could be stored in, and released by, synaptic vesicles (Lebrand et al., 1998).  It is  
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Figure 7.  Pb exposure does not result in significant changes in the total brainstem levels 
of 5-HT and 5HIAA in P4 mice.  A, B: Total brainstem levels of 5-HT (A) and its 
metabolite 5HIAA (B) do not significantly change with Pb exposure in P4 mice.  C: The 
5-HT turnover ratio (5HIAA/5-HT) does not change with Pb exposure in P4 mice, 
indicating Pb does not change 5-HT degradation.  Graphs represent mean ± SEM.  
ANOVA with Dunnett’s post hoc test (n = 5). 
A	   5HT-­‐P4-­‐brainstem	  
B	   5HIAA-­‐P4-­‐brainstem	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not known whether the 5-HT immunoreactive LSO neurons also transiently express 
VMAT2.    
To determine whether Pb affects VMAT2 expression in the LSO, control and Pb-
exposed brainstem sections from P4 and P8 mice were immunostained for VMAT2.  P4 
mice showed very little VMAT2 immunostaining (data not shown).  VMAT2 immuno-
positive LSO somata were observed in control and Pb-exposed mice at P8 (Figure 8).  
Figure 8 also illustrates that the majority of VMAT2 immunolabel is localized in 
processes.  Very low levels of Pb exposure significantly decreased VMAT2 
immunoreactivity in the LSO (Figure 8B, D).   In contrast, low Pb exposure did not affect 
VMAT2 immunoreactivity (Figure 8C).  Quantification of VMAT2 staining confirmed a 
significant decrease of VMAT2 immunostaining in the very low Pb exposed mice 
compared to control mice (Figure 8D).   
 These findings demonstrate that Pb decreases VMAT2 immunoreactivity in LSO 
neurons, and also suggests that Pb decreases the density of monoaminergic synapses.   
Because we have shown in the current study that Pb does not appear to change the 
serotonergic innervation in LSO, one possibility is that Pb affects synaptogenesis of other 
monoaminergic neurons.   
 
Pb exposure decreases total DA and DOPAC levels in the brainstem  
 To further investigate whether Pb also affects other monoaminergic neurons such 
as dopaminergic neurons, levels of dopamine (DA) and major metabolites of DA, 
including 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), were 
measured in crude brainstem fractions of P4 mice by HPLC analysis.  Both the very low  
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Figure 8.  Pb exposure decreases immunofluorescence labeling (green) for the vesicular 
monoamine transporter 2 (VMAT2) in the LSO of P8 mice.  A-C: Immunoreactivity for 
VMAT2 in the LSO decreases with very low Pb exposure (B) compared to no Pb control 
(A).  Low Pb exposure (C) does not result in changes in the total VMAT2 expression.  D:  
Quantification of VMAT2 immunostaining in the LSO confirms that this decrease is 
statistically significant in very low Pb exposed mice.  Graphs represent mean ± SEM.  
*p<0.05; ANOVA with Dunnett’s post hoc test (n = 5).  Scale bar = 30 µm.   
*	  
D	   	  	  	  	  VMAT2-­‐P8-­‐LSO	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and low Pb significantly decreased brainstem levels of DA and DOPAC compared to 
controls (Figure 9A, B).  In contrast, HVA levels in brainstem fractions did not change 
with Pb (Figure 9C).  DA turnover ((DOPAC+HVA)/DA) was also not affected by Pb, 
suggesting that Pb does not affect degradation of DA in the brainstem (Figure 9D).    
The Pb-induced decreases in total brainstem levels of DA are correlated with 
decreased VMAT2 expression, and further support the hypothesis that Pb may affect 
synaptogenesis of non-serotonergic monoamine neurons.   
 
The Pb-induced delay in the normal developmental uptake of 5-HT by LSO neurons 
is correlated with decreased immunoreactivity for synaptophysin 
 Alterations in 5-HT homeostasis during development have been associated with 
disrupted synapse formation, thus modifying the fine wiring of neural connections in the 
brain (Gaspar et al., 2003).  We also found that Pb exposure decreases VMAT2 
expression in the LSO, suggesting that Pb impairs synaptic maturation within the LSO.  
To further examine whether the Pb-induced delay in the normal developmental uptake of 
5-HT by LSO neurons is correlated with a loss of synapses, control and Pb-exposed 
brainstem sections from P8 mice were immunostained for synaptophysin (SYP), a marker 
of presynaptic terminals, and thus a good indicator of synaptic density.  Very low Pb 
exposure resulted in a significant decrease in SYP labeling within LSO (Figure 10B, D) 
compared to control (Figure 10A).  Low Pb exposure showed a slight decrease, but this 
change was not statistically significant (Figure 10C, D).  Both VMAT2 and SYP 
decreased with Pb exposure, suggesting that the loss of synapses within LSO is primarily 
due to decreases in monoaminergic synapses.  These findings indicate that Pb exposure  
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Figure 9.  Pb exposure decreases total brainstem levels of DA and DOPAC in P4 mice.  
A, B: Total brainstem levels of DA (A) and DOPAC (B) significantly decreases with Pb 
exposure in P4 mice.  C: HVA levels in the brainstem do not change with Pb exposure.  
D: The DA turnover ratio ((DOPAC+HVA)/DA) does not change with Pb. Graphs 
represent mean ± SEM.  *p<0.05; ANOVA with Dunnett’s post hoc test (n = 5). 
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Figure 10.  Pb exposure decreases synaptophysin (SYP) immunofluorescence labeling 
(green) in the LSO of P8 mice.  A-C: Immunoreactivity for SYP decreases with very low 
Pb exposure (B) compared to control (A).  Low Pb exposure (C) does not result in 
changes in the SYP expression.  D:  Quantification of SYP immunostaining in the LSO 
confirms that decrease is statistically significant in very low Pb exposed mice.  Graphs 
represent mean ± SEM.  *p<0.05; ANOVA with Dunnett’s post hoc test (n = 5).  Scale 
bar = 30 µm.   
* 	  *	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indeed alters the synaptic density within the LSO, and modulation of 5-HT uptake by 
LSO neurons may be one mechanism by which Pb affects synaptic maturation within the 
LSO. 
 
The Pb-induced delay in the normal developmental uptake of 5-HT by LSO neurons 
is correlated with decreased immunoreactivity for GAP-43 
 Growth associate protein (GAP-43) is a marker for axonal elongation and 
maturation of presynaptic endings, and has been shown to be strongly expressed in the 
LSO during postnatal development.  In P1 rats, GAP-43 immunostaining shows a diffuse 
distribution pattern, which is thought to indicate active axonal elongation.  By P8, GAP-
43 staining becomes restricted to the neuropil, likely reflecting the formation of more 
mature synapses (Horvath et al., 1997).  In order to test whether the Pb-induced decreases 
in SYP and VMAT2 expressions are correlated with a decreased expression of GAP-43, 
control and Pb-exposed brainstem sections from P4 and P8 mice were immunostained for 
GAP-43.  Figure 11A illustrates that there are high levels of GAP-43 immunostaining 
within the LSO of P4 control mice that is characterized by a diffuse distribution pattern.  
Low Pb exposure resulted in a significant decrease of GAP-43 expression in the LSO 
(Figure 11D).  Very low Pb exposure showed two different patterns of GAP-43 staining, 
one group of animals demonstrated decreases in GAP-43 expression (Figure 11C, n=3), 
while the other group showed increases in GAP-43 immunoreactivity (Figure 11B, n=2).  
This differential response to very low Pb exposure likely indicates that P4 is a transition 
point for Pb-induced changes in GAP-43 expression within the LSO. 
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 By P8, the control LSO showed a more granular pattern of GAP-43 
mmunostaining (Figure 12A).  Pb exposure resulted in decreased GAP-43 
immunolabeling in the LSO (Figure 12B, C).  Quantification demonstrated that the 
staining intensity of GAP-43 in the low Pb group was significantly decreased compared 
to control mice (Figure 12D) while very low Pb resulted in a decreasing trend of GAP-43 
staining.  The changes in GAP-43 immunostaining further support the hypothesis that Pb 
exposure disrupts the normal development of synapses within the LSO. 
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Figure 11.  Pb exposure alters GAP-43 immunofluorescence labeling in the LSO of P4 
mice.  A -D: Immunoreactivity for GAP-43 in the LSO decreases with low Pb exposure 
(D) compared to control mice (A).  Very low Pb exposure shows two different patterns of 
GAP-43 expression, one group shows a decrease GAP-43 labeling (C, n=3) and the other 
group shows an increase in GAP-43 expression (B, n=2).  E: Quantification of GAP-43 
immunostaining in the LSO confirms the statistical significance of the effect of Pb.  
Graphs represent mean ± SEM.  *, # p<0.05; ANOVA with Dunnett’s post hoc test (n = 
5).  Scale bar = 15 µm.   
E	   GAP43-­‐P4-­‐LSO	  
*	   *	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Figure 12.  Pb exposure decreases GAP-43 immunofluorescence (green) labeling in the 
LSO of P8 mice.  A-C: Immunoreactivity for GAP-43 in the LSO decreases with both 
very low (B) and low (C) Pb exposure compared to control (A).  D:  Quantification of 
GAP-43 immunostaining in the LSO confirms this decrease is statistically significant in 
low Pb exposed mice.  Graphs represent mean ± SEM.  *p<0.05; ANOVA with 
Dunnett’s post hoc test (n = 5).  Scale bar = 15 µm.             
D	   GAP43-­‐P8-­‐LSO	  
*	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Discussion 
 The current study demonstrates that Pb exposure delays the normal developmental 
uptake of 5-HT by LSO neurons in early postnatal mice (P4 and P8).  This effect of Pb is 
specific for transient uptake because Pb does not alter 5-HT immunostaining in the 
serotonergic processes that are thought to originate from the raphe.  Results from double 
immunofluorescence staining of 5-HT and SERT indicate that Pb prolongs the expression 
of SERT in the LSO neurons.  Pb did not affect synthesis or degradation of 5-HT in the 
entire brainstem, further supporting the hypothesis that Pb alters the transient uptake of 5-
HT by LSO neurons through changes in SERT expression.  The loss of VMAT2 and SYP 
immunostaining within the LSO indicates that delayed developmental uptake of 5-HT by 
LSO neurons could be responsible for the decreased synaptic density in the LSO.  The 
changes in GAP-43 immunostaining further support the hypothesis that Pb disrupts 
axonal arborization and synaptic maturation in the LSO, and also suggest that GAP-43 
may be a target molecule for Pb.  Finally, total brainstem levels of DA and DOPAC 
decreased with Pb exposure suggesting that Pb may affect the dopaminergic system as 
well.   
 
The presence of SERT in LSO somata of a non-genetically modified mouse  
 LSO neurons receive glutamatergic excitatory input from the ipsilateral 
anteroventral cochlear nucleus (AVCN) and glycinergic inhibitory input from the 
contralateral medial nucleus of the trapezoid body (MNTB) (von Gersdorff and Borst, 
2002).  LSO ascending neurons project to the ipsilateral and contralateral inferior 
colliculus (IC) and use glycine and glutamate as a neurotransmitter and are not 
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considered to be intrinsic serotonergic neurons (Thompson and Schofield, 2000).  During 
development, these “non-serotonergic” LSO neurons become transiently immuno-
positive for5-HT.  In MAOA knockout mouse where brain 5-HT levels are increased up 
to 6-9 fold compared to wild type, a subset of LSO neuronal somata transiently contain 5-
HT immunostaining starting from embryonic day 18 (E18), reaching maximal levels at 
birth (P0) to postnatal day 7 (P7).  This serotonin immunoreactivity then disappears by 
P10 (Cases et al., 1998).  5-HT immunoreactive LSO somata are also present in wild type 
mice at P1 and then mostly disappear by P8 (Thompson, 2006).   
Unlike intrinsic serotonergic neurons, the 5-HT containing LSO neurons do not 
have the capacity for synthesizing 5-HT, as evidenced by the lack of tryptophan 
hydroxylase (TPH), a rate-limiting enzyme in 5-HT synthesis (Thompson and Thompson, 
2008, and current study).  Instead, Thompson and Thompson 2008 proposed that LSO 
neurons take up extracellular 5-HT through SERT, a high affinity 5-HT transporter.  In 
MAOA k/o mice, 5-HT and SERT staining is co-localized in LSO somata at P0 and P5-6, 
and all staining in the LSO somata for both proteins disappears by P15 (Thompson and 
Thompson, 2009a).  In the current study, we also found that 5-HT and SERT are co-
localized in the LSO somata of P4 and P8 wild type mice.  However, the present study is 
the first to demonstrate the existence of SERT protein in 5-HT immuno-positive LSO 
somata in a non-genetically modified mouse, demonstrating that transient expression of 
5-HT and SERT is a normal developmental process and is not due to the abnormally high 
levels of 5-HT in the MAOA k/o mouse.   
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Pb and SERT expression 
The mechanism by which LSO somata transiently express SERT is not clear.  The 
active (functional) SERT is located mainly in axon terminals and along the axons of 
serotonergic neurons (Zhou et al., 1998).  In thalamocortical neurons that transiently 
accumulate 5-HT through SERT, SERT proteins are transiently expressed in the axons 
and axon terminals, and are responsible for taking up 5-HT from the extracellular space.  
This 5-HT is then retrogradely transported to the thalamic neuronal cell bodies in the 
ventroposterior thalamus (Lebrand et al., 1996; Lebrand et al., 1998).  In our model, 
SERT is expressed directly in LSO neurons themselves and it should be noted that the 
effect of Pb appears to be specific for the transient expression of SERT in the LSO 
neurons.  Pb does not affect SERT expression in LSO processes. 
Factors regulating SERT expression in non-serotonergic neurons are poorly 
understood.  In serotonergic neurons, the transcription factor Pet1 directly activates the 
transcription of genes that encode TPH, ADAC (L-amino acid decarboxylase), and SERT 
(Hendricks et al., 1999).  However, this gene is not found in neurons transiently 
expressing SERT (Pfaar et al., 2002).   
Interestingly, thyroid hormones have been shown to regulate the transient 
expression of SERT in thalamocortical neurons (Auso et al., 2001).  Auso et al., reported 
that transient expression of the SERT gene disappears by P11 in normal mice, whereas its 
expression persists until P15 in hypothyroid rats (Auso et al., 2001).  Furthermore, this 
effect of hypothyroidism is specific for the transient expression SERT, because there is 
no general delay in brain maturation and SERT is not changed in raphe neurons.  
Prolonged expression of SERT in hypothyroid rats also leads to reduced axon terminal 
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arborization and synaptogenesis within the cortical barrel fields, resulting in a smaller 
barrel area.  We found that Pb exposure is also correlated with decreased synaptic 
density.  Interestingly, Pb has been shown to reduce free thyroxine (FT4) levels in Pb 
exposed adolescents whose average blood Pb level is 7.3 ± 2.92 µg/dL (Dundar et al., 
2006).  In addition, Pb exposure reduces 131I uptake in animals and impairs the release of 
thyroid-stimulating hormone (TSH) in children (Slingerland, 1955; Huseman et al., 
1987).  Therefore, a Pb-induced impairment in thyroid function is one potential 
mechanism by which Pb might delay the transient expression of 5-HT and SERT in non-
serotonergic LSO neurons.  Future studies will address this issue. 
 
Possible mechanism of Pb induced impaired synapse formation within the LSO  
Precise regulation of transient uptake of 5-HT by “non-serotonergic” sensory 
neurons has been shown to be critical for the proper formation of highly topographically 
organized sensory maps (Gaspar et al., 2003).  Studies suggest that this transient uptake 
of 5-HT by non-serotonergic sensory neurons is necessary to clear 5-HT away from the 
extracellular space, thereby maintaining proper extracellular concentrations of 5-HT 
during a critical period of development.  It is well known that 5-HT functions as a 
neurotrophic factor during brain development prior to the time when it plays a role as a 
neurotransmitter (Luo et al., 2003).  Depletion of 5-HT levels during development has a 
long lasting effect on synaptogenesis and brain maturation and maintaining proper 5-HT 
levels during the critical period of brain development is crucial (Lou et al., 2003; Gaspar 
et al., 2002).  For example, embryonic or neonatal depletion of 5-HT has been shown to 
decrease synaptic density, reduce both spine density and complexity of cortical pyramidal 
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neurons and hippocampal dentate granule cells (Mazer et al., 1997; Vitalis et al., 2007), 
and alter the neural morphology of somatosensory cortical barrel fields (Bennett-Clarke 
et al., 1994).   
We found in the current study that Pb exposure delays the normal uptake of 5-HT 
by LSO neurons.  Thus, an intriguing hypothesis is that Pb could shift the extracellular 
concentrations of 5-HT during a critical window of neuronal development, thereby 
resulting in disrupted axonal arborization and synaptogenesis in the LSO.  In support of 
this, we found that Pb decreases SYP immunostaining within the LSO of P8 mice.   
 
5-HT, GAP-43, and synaptogenesis 
Despite the growing evidence demonstrating the detrimental effect of 5-HT 
depletion on synaptogenesis and brain maturation, the factors that mediate these 
outcomes, especially in the non-serotonergic sensory neurons, remain largely unknown.  
One possible candidate is GAP-43.  GAP-43 is expressed early in development and plays 
a role in axonal outgrowth and synaptic plasticity in response to extracellular signals 
(Luo et al., 2003).  GAP-43 has shown to be upregulated during the period of barrel field 
formation, and is then subsequently downregulated (Maier et al., 1999).  In GAP-43 k/o 
mice, thalamocortical axons fail to innervate the cortex, thus barrels are not formed, and 
forebrain levels of 5-HT and 5HIAA are decreased (Donovan et al., 2002).  These studies 
suggest that GAP-43 may be a factor that mediates the 5-HT induced regulation of 
sensory neuron development.  Within the rat LSO, GAP-43 is upregulated from P1 to P8, 
and then is subsequently downregulated until P21 (Horvath et al., 1997).  Our results 
demonstrate that Pb exposure also decreases GAP-43 expression in the developing LSO, 
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perhaps through the Pb-induced changes in extracellular 5-HT levels.  Thus, modulation 
of GAP-43 by changes in 5-HT levels is one potential mechanism by which Pb might 
impair the normal development of synapses within the LSO.   
Finally, in addition to its action as a trophic factor, 5-HT could modulate 
spontaneous activity in the LSO, thereby affecting LSO development.  Within slice 
preparations of gerbil LSO neurons, 5-HT application activates prolonged bursts of 
spontaneous inhibitory postsynaptic currents (IPSCs) in young animals but this effect is 
not observed after P8 (Fitzgerald and Sanes, 1999).  Amplifying inhibitory transmission 
of the LSO in the first postnatal week prevents the normal developmental refinement of 
LSO dendrites and MNTB terminal arborizations (Sanes and Chokshi, 1992; Sanes et al., 
1992; Sanes and Hafidi, 1996).  Thus, an intriguing hypothesis is that Pb induces 
increased concentrations of extracelluar 5-HT in the early postnatal period, resulting in 
increased frequency of IPSCs that then inhibit proper axonal arborization and synapse 
formation. 
 	  
Pb and dopaminergic system 
 Our finding that Pb exposure decreases the expression of VMAT2 within the LSO 
of P8 mice and reduces DA and DOPAC levels in the P4 brainstem suggests that Pb may 
affect other monoaminergic systems  including dopaminergic systems within the LSO.  In 
support of this hypothesis, Pb has been shown to decrease brain levels of DA and the 
major metabolites of DA, including 3,4-dihydroxyphenylacetic acid (DOPAC) and 
homovanillic acid (HVA), in various brain regions (Antonio et al., 1996; Antonio and 
Leret, 2000; Devi et al., 2005; Szczerbak et al., 2007).  The effect of Pb on DA is 
dependent both on the dose and the length of time it is administered and it is thought that 
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Pb administered during development has a long lasting effect on DA metabolism 
(Szczerbak et al., 2007).  Future studies that include double-label immunofluorescence 
for tyrosine hydroxylase (TH, a marker for dopaminergic neurons) and SYP are needed to 
determine whether the decreased SYP staining that we observe in the Pb-treated P8 LSO 
reflects a decrease in synapses of dopaminergic neurons.   
 
Summary and Conclusion 
 The current study demonstrates that Pb exposure delays the normal developmental 
uptake of 5-HT by LSO neurons during a critical period of development, through the 
delayed expression of SERT in LSO neurons.  SERT appears to be a target for Pb, 
because Pb did not affect either synthesis or degradation of 5-HT in the entire brainstem .  
Thus, neurons such as LSO neurons that transiently take up 5-HT during development 
may be specific cellular targets of Pb.  The delayed uptake of 5-HT by LSO neurons was 
also correlated with the decreased expression of SYP, VMAT2 and GAP-43 within the 
LSO, suggesting that the delayed uptake of 5-HT by LSO neurons may be one 
mechanism by which Pb impairs synaptic maturation  within the LSO.  These synaptic 
changes persistinto adulthood (Fortune and Lurie, 2009) and studies are in progress to 
elucidate the permanent effect of Pb on the developing LSO. 
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CHAPTER II. 
LOW-LEVEL Pb EXPOSURE DURING DEVELOPMENT PERMANENTLY 
ALTERS SEROTONERGIC INNERVATION IN THE LSO AND IC OF ADULT 
MICE 
 
Abstract 
During early postnatal development, certain “non-serotonergic” sensory neurons, 
including LSO neurons, transiently take up 5-HT from the extracellular environment, and 
disruption of this transient uptake has been shown to cause permanent changes in adult 
behavior and result in modifications to the fine wiring of neural connections in the brain.  
We have previously shown that developmental Pb exposure results in a delay in the 
uptake of 5-HT by early postnatal LSO neurons, and that this delay is correlated with 
altered synaptic maturation (chapter I).  Because developmental Pb exposure decreases 5-
HT and VMAT2 expression in the adult LSO (Fortune and Lurie, 2009), the 
developmental effects of Pb seem to persist into adulthood.  The current study was 
undertaken to determine whether developmental Pb exposure has an acute effect on the 5-
HT system in the adult central auditory system of the brainstem or whether the decrease 
in VMAT2 and 5-HT observed in the adult is largely due to changes in process 
arborization and synaptogenesis during development.  Mice were exposed to very low Pb 
(0.01mM) or low Pb (0.1mM) throughout gestation and until postnatal day 21 (P21).  
Brainstem levels of 5-HT and its metabolite, 5-hydroxindole-3-acetic acid (5HIAA), were 
measured by HPLC analysis and VMAT activity was measured in isolated synaptic 
vesicles.  Brainstem sections from control and Pb exposed mice were immunostained for 
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SERT and GAP-43.  Pb increased brainstem levels of 5-HT but did not change 5-HT 
degradation, even though 5-HT immunostaining within the LSO decreased.  Pb had no 
effect on SERT immunoreactivity within the LSO or on VMAT activity.  These findings 
demonstrate that the Pb induced decreases in 5-HT expression within the P21 LSO do not 
appear to be an acute effect of Pb on the metabolism of 5-HT.   Similar trends were 
observed in the IC, where Pb caused an increase in 5-HT expression within CINC, but no 
change in total IC 5-HT levels or metabolism, or in SERT immunostaining.   Finally, 
GAP-43 immunoreactivity (a marker of synaptic development) was modified in the adult 
Pb-exposed LSO, adding support to the hypothesis that developmental Pb exposure 
modulates process arborization and synaptogenesis during the early postnatal period, and 
these changes persist into adulthood. 
 
Introduction  
Lead (Pb) continues to be a significant environmental toxin.  Despite its 
elimination from household paint, leaded pipes, and food cans, Pb is still found in leaded 
paint and pipes in old residences, leaded gasoline used by off-road vehicles, toys with 
leaded paint, cosmetics, folk medicines, glazed ceramics, bullets, and storage battery 
casings (Bellinger and Bellinger, 2006; Bellinger, 2008).  The developing central nervous 
system (CNS) has long been recognized as a primary target for environmental Pb 
exposure, thus children are most vulnerable (Landrigan and Todd, 1994; Moreira et al., 
2001).  In addition, the Centers for Disease Control (CDC) reported that Pb exposure 
during the first 6 years of life can produce permanent neurological damage (CDC, 1991), 
indicating that the effects of developmental Pb exposure persist into adulthood.  
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Moreover, several studies in animals suggest that exposure to Pb during gestation and the 
early postnatal period produces greater deficits in learning performances than Pb 
exposure in older animals (Jett et al., 1997; Kuhlmann et al., 1997).  Thus, there seems to 
be a critical period of brain development in which neuronal processes are highly 
vulnerable to the presence of Pb (Toscano and Guilarte, 2005). 
Currently, the CDC limit of concern for childhood blood Pb level remains at 10 
µg/dL, however, recent data suggests that there is no safe level of Pb.  Blood Pb levels 
lower than 10 µg/dL can produce neurobehavioral-cognitive deficits in children, 
including IQ decline, and attention deficit hyperactivity disorder (ADHD) (Bellinger and 
Bellinger, 2006; Braun et al., 2006; Bellinger, 2008).  Pb exposure is also associated with 
deficits in central auditory temporal processing (Finkelstein et al., 1998; Lurie et al., 
2006; Jones et al., 2008), and, interestingly, children with ADHD have been shown to 
have deficits in auditory temporal processing (Breier et al., 2003; Facoetti et al., 2003; 
Putter-Katz et al., 2005; Wright and Conlon, 2009).  Compared to the intensive studies 
conducted on the effect of developmental Pb exposure on cognitive disorders, the cellular 
mechanism underlying Pb-induced sensory system dysfunction, including dysfunction of 
the central auditory system, is largely unknown.   
We have previously reported that low-level Pb exposure during development 
decreases the expression of serotonin (5-HT) and the vesicular monoamine transporter 2 
(VMAT2) in brainstem auditory nuclei, particularly in the lateral superior olive (LSO), 
suggesting that the serotonergic system is a target of Pb (Fortune and Lurie, 2009).  
During development, certain “non-serotonergic” neurons, including the principle 
projection neurons of the auditory, visual, and somatosensory system transiently take up 
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5-HT through temporary expression of the serotonin re-uptake transporter, SERT (Gaspar 
et al., 2003).  Disruption of this transient uptake has been shown to cause permanent 
changes in adult behavior and to result in modifications to the fine wiring of neural 
connections in the brain (Gaspar et al., 2003).  In the auditory system, a subset of LSO 
neurons transiently expresses 5-HT during the peri and postnatal period (Cases et al., 
1998; Thompson, 2006).  We have previously shown that developmental Pb exposure 
results in a delay in the uptake of 5-HT by postnatal LSO neurons, and that this delay 
delay is correlated with altered synaptic maturation (chapter I).  Because we also 
observed decreases in 5-HT and VMAT2 immunoreactivity in the adult LSO following 
developmental Pb exposure (Fortune and Lurie, 2009), it may be that Pb results in the 
mis-wiring of neuronal connections that persist into adulthood.  Alternatively, the Pb 
induced changes in 5-HT and VMAT2 immunoreactivity within the adult LSO could be a 
result of an acute effect of Pb on 5-HT metabolism.  In fact, Pb has been shown to alter 
brain 5-HT levels following acute exposure in the adult animal (Xu et al., 2005).  
The current study was undertaken to determine whether developmental Pb 
exposure has an acute effect on the 5-HT system in the adult central auditory system of 
the brainstem or whether the decrease in VMAT2 and 5-HT observed in the adult is 
largely due to changes in process arborization and synaptogenesis during development as 
we have previously suggested (chapter I).  HPLC was utilized to measure whether Pb 
affects 5-HT metabolism in the adult and VMAT activity was measured in isolated 
synaptic vesicles to determine whether Pb acutely modulates the loading of 5-HT into 
presynaptic vesicles.  In addition, brainstem sections from P21 control and Pb-exposed 
mice were immunostained for SERT to establish whether the transporter expression is 
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changed by Pb in the adult.  Finally, the serotonergic system within the central nucleus of 
Inferior Colliculus (IC) was examined to ascertain whether Pb disrupts 5-HT within a 
major target of the LSO.  
We found that Pb exposure increased brainstem levels of 5-HT, even though 5-
HT immunostaining within the LSO decreases.  Thus, the effect of Pb on the LSO is 
specific to that nucleus and is not a general response of the brain to Pb.  Pb had no effect 
on SERT immunoreactivity within the LSO or on VMAT activity.  Taken together, these 
findings demonstrate that the Pb induced decreases in 5-HT immunostaining within the 
P21 LSO are not the result of altered synthesis, degradation or re-uptake of 5-HT.   We 
found similar trends in the IC, although in this case Pb caused an increase in 5-HT 
immunoreactivity within the central nucleus, but no change in total 5-HT levels within 
the IC or in SERT immunostaining.  Again these studies indicate that the Pb-induced 
increases in 5-HT immunoreactivity within the IC are not the result of altered synthesis, 
degradation, or re-uptake of 5-HT.  Finally, GAP-43 immunoreactivity (a marker of 
synaptic development) was modified in the adult Pb-exposed LSO, adding support to the 
hypothesis that developmental Pb exposure modulates process arborization and 
synaptogenesis during the early postnatal period, and these changes persist into 
adulthood. 
 
Materials and Methods 
Chronic lead exposure to CBA/CaJ mice 
 Breeding pairs of CBA/CaJ mice were obtained from the Jackson Laboratory (Bar 
Harbor, MA).  Mice were maintained in microisolator units and kept in the University of 
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Montana specific pathogen free animal facility.  Cages, bedding, and food were sterilized 
by autoclaving and mice were handled with aseptic gloves.  Mice were allowed food and 
water ad libitum.  All animal use was in accordance with NIH and University of Montana 
IACUC guidelines.  Breeding pairs of CBA mice were randomly assigned to three groups 
having unlimited access to water (pH 3.0) containing 0 mM (control), 0.01 mM (very 
low) or 0.1 mM (low) lead acetate.  Offspring were exposed to lead throughout gestation 
and through the dam’s milk until sacrifice on postnatal day 21 (P21).  
 
Tissue preparation for Immunohistochemistry 
 Mice were deeply anesthetized using 2’,2’,2’-tribromoethanol (TBE) and perfused 
transcardially with 4% Na-periodate-lysine-paraformaldehyde fixative (PLP, final 
concentrations 0.01M sodium periodate, 0.075M lysine-HCl, 2.1% paraformaldehyde, 
0.037M phosphate).  Brains were removed and post-fixed in PLP overnight at 4°C, rinsed 
3 times for 10 minutes each in phosphate buffered saline (PBS) and transferred to a 20% 
sucrose solution in PBS for 2 days at 4°C.  Finally, brains were transferred to a 1:1 
mixture of a 20 % sucrose solution in PBS and Optimal Cutting Temperature (O.C.T.) 
compound (Sakura Finetek, Torrance, CA) for 1-2 days at 4°C.  Brains were embedded 
into 1.5 cm square embedding cups filled with O.C.T. compound, and then frozen in dry 
ice and 100% ethanol and stored at -20°C.  Ten micron tissue sections were cut on a 
Thermo Shandon Cryotome Cryostat (Thermo Shandon, Pittsburg, PA) and a one in three 
series was collected for each brain.    
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Immunohistochemistry   
 Sections were thawed to room temperature and rinsed in PBS three times for 10 
minutes each.  Sections were then permeabilized for 30 minutes in 0.5% Triton X-100 in 
PBS and blocked for 30 minutes with 4% of the normal goat serum (Vector Laboratories, 
Burlingame, CA) in PAB (1% sodium azide, 0.5% bovine serum albumin in PBS) and 
incubated with primary antibody for 1-2 days in a humid chamber at 4°C.  The sections 
were rinsed in PBS three times for 10 minutes each and incubated with the goat Alexa 
Fluor-488 anti-rabbit secondary antibody (1:400, Invitrogen, Grand Island, NY) in PAB 
for 1 hour at room temperature in the dark.  Sections were then rinsed in PBS followed by 
distilled water and coverslipped with FluorSaverTM (Calbiochem®, San Diego, CA) and 
stored at 4°C.  The primary antibodies used for immunohistochemistry were as follows:  
rabbit polyclonal anti-5-HT (1:10,000); rabbit polyclonal anti-VMAT2 (1:2000), rabbit 
polyclonal anti-SERT (1:250); rabbit polyclonal anti-GAP-43 (1:1000).   
 
Antibodies 
 The rabbit polyclonal against serotonin (5-HT) was raised in rabbit against 
serotonin coupled to bovine serum albumin with paraformaldehyde (Cat. No. 20080, 
ImmunoStar Inc., Hudson, WI).  No cross-reactivity of the serotonin antisera was seen 
with 5-hydroxytrytophan, 5-hydroxyindole-3-acetic acid, and dopamine (manufacturer’s 
specifications).   This 5-HT antibody labels our mouse brainstem sections in a staining 
pattern virtually identical to that of other studies using the same antiserum to label the 
mouse superior olive and inferior colliculus (Hurley et al., 2002; Thompson 2006).  This 
antibody has also been characterized in our mouse system (Fortune and Lurie, 2009).  In 
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addition, preadsorption with the 5-HT/bovine serum albumin (BSA) conjugate protein 
(20 µg/ml, Cat. No. 20081, ImmunoStar Inc., Hudson, WI) eliminates all 
immunoreactivity, whereas preadsorption with BSA does not affect immunostaining.   
 The rabbit polyclonal antibody against the serotonin transporter (SERT) was 
raised in rabbit against the synthetic peptide sequence corresponding to amino acids (602-
622) of the rat 5-HT transporter coupled to keyhole limper hemocyanin (Cat. No. 24330, 
ImmunoStar Inc., Hudson, WI).  This SERT antibody labels our mouse brainstem 
sections in a staining pattern virtually identical to that observed in mouse superior olive 
(Thompson and Thompson, 2008). 
The rabbit polyclonal antibody against the vesicular monoamine transporter 2 
(VMAT2, C-terminal) was raised in rabbit against the synthetic peptide comprising 
amino acids sequence (496-515) at the cytoplasmic C-terminus of rat VMAT2 (Cat. No. 
135402, Synaptic System, Gottingen, Germany).  This VMAT2 antibody labels our 
mouse brainstem sections in a staining pattern virtually identical to that observed in the 
rat median eminence (Weihe et al., 1996) and has been previously characterized in our 
system (Fortune and Lurie, 2009). 
The rabbit polyclonal anti-GAP43 was raised in rabbit against the GAP-43 
synthetic peptide sequence corresponding to amino acids (216-226) of rat GAP-43 (Cat. 
Ab7462, Abcam Inc., Cambridge, MA).  This GAP-43 antibody labels our mouse 
brainstem sections in a staining pattern virtually identical to that observed in the rat optic 
nerve (Lingor et al., 2007), and the rat superior olive (immunostained with a different 
mouse monoclonal antibody against GAP-43 (Roche; Horvath al., 1997)). 
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Tissue Imaging and analysis 
All fluorescent slides were viewed with a 60x objective using either a Bio-Rad 
Radiance 2000 Confocal microscope or an Olympus FV 1000 Fluoview Confocal 
microscope.  Quantitative analysis for immunostaining was performed as previously 
described (Fortune and Lurie, 2009).  Briefly, images were collected and then converted 
from color tiff files to black and white 12-bit tiff files, and the integrated optical density 
(IOD) of the immunostaining was measured using MediaCybernetics Image-Pro software 
(Bethesda, MD).  IOD measurements were used for quantification of immunostaining 
because it analyzes both the area of immunostained tissue that met threshold as well as 
the intensity of the immunostaining.  A threshold of immunostaining in control (No Pb) 
animals was set for each antibody such that all immunoreactivity met threshold, and was 
used as a comparison with the Pb treatment groups.  Immunostaining within the LSO and 
IC in control and Pb-exposed mice were then quantified and averaged.  Statistical 
differences in immunostaining between control and Pb-exposed mice were analyzed 
using KaleidoGraph software (Synergy Software, Reading, PA) or GraphPad Prism 4.0 
software (GraphPad Software, La Jolla, CA). 
 
Sample preparation for HPLC analysis  
Brainstems from P21 mice were dissected using a 1mm mouse brain matrix.  
First, a 1mm thick section was cut and the inferior colliculus region (IC) was separated 
from the rest of midbrain.  Then, a 2mm thick section was cut and frozen on a razor blade 
using liquid nitrogen and dissected into two separate regions: the ventral brainstem region 
(VBS), containing the superior olivary complex (SOC), and the dorsal brainstem region 
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(DBS), containing no auditory nuclei.  In terms of the raphe nuclei, the DBS fraction 
contains most of the rostral group nuclei, including the dorsal and median raphe, and the 
VBS fraction contains most of the caudal group of the raphe (including the raphe 
pallidus, and magnus), and part of the rostral group nuclei, including the median raphe.  
These fractions were immediately weighed and individual VBS, DBS, and IC fractions 
from three mice were then combined, and homogenized in 150 µl of 0.05 M perchloric 
acid solution (PCA) containing 3,4-dihydrobenzylamine (DBA, 31ng/ml) as an internal 
standard (Branson Sonifier 150, Branson, Danbury, CT), and stored at -20 ºC until ready 
to use. 
 
RP-HPLC analysis of 5HT/5HIAA 
 5-HT and its metabolite, 5-hydroxyindole-3-acetic acid (5-HIAA) levels were 
measured using reverse phase high performance liquid chromatography (RP-HPLC) with 
electrochemical detection.  The homogenates were centrifuged at 14,000 x g for 20 min at 
4ºC and the supernatants were filtered through a Millex® hydrophilic LCR (PTFE) 0.45 
um filter (Millipore, Bedford, MA).  Sample filtrates were loaded into autosampler vials 
and were placed into an ESA Model 5 autosampler (ESA, Chelmsford, MA).  An 
OmniSpher 5 C18 chromatographic column (Varian Inc., Lake forest, CA) with a length 
of 25 cm and an internal diameter of 4.6 mm was used to separate analytes.  The mobile 
phase consisted of water:acetonitrile (9:1, vol/vol) containing 0.15 M monochloroacetic 
acid, 0.12 M sodium hydroxide, 0.6 mM EDTA and 1.30 mM sodium octyl sulfate, and 
the pH was adjusted to 3.2 with glacial acetic acid.  A constant flow rate of 1ml/min was 
maintained and the column effluent was analyzed with a Model 5600A ESA CoulArray® 
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electrochemical detector (ESA, Chelmsford, MA).  Potentials of the three ESA Model 
6210 four channel electrochemical cells, placed in series, were as follows: (channels 1 
through 5)-50, 0, 25, 100, 200 mV, (6 through 12) 300 mV.  5-HIAA and 5-HT were 
monitored at 200 mV.  Peak area ratios were used to calculate 5-HT and 5-HIAA levels 
from a calibration curve (peak area of analyte/ peak area of DBA).   
 
Vesicular Monoamine Transporter (VMAT) Assay 
Synaptic vesicles were isolated according to the method of Kish and Ueda (1989), 
and modified accordingly (Kish and Ueda, 1989; Bartlett et al., 1999).  Sprague-Dawley 
rats (200-220 g) were sacrificed by decapitation.  The brains were removed and minced 
in ice cold buffer containing 0.32 M sucrose, 1.0 mM NaHCO3, 1.0 mM magnesium 
acetate, and 0.5 mM calcium acetate (pH 7.2).  The minced brains were homogenized 
(motorized Potter-Elvejham, Teflon/glass; Wheaton) and centrifuged for 15 min at 
12,000g (4ºC, Sorvall SS-34 rotor, Du Pont, Newton, CT).  The resulting pellets were 
resuspended in an ice-cold lysing solution (6 mM Tris-maleate, pH 8.1) for 45 min and 
centrifuged at 43,000g for 15 min.  Supernatants were then centrifuged for 55 min at 
222,000g (Beckman Ti 70 rotor; Beckman Instrumentation, Fullerton, CA).  The final 
pellets were resuspended by homogenization in 0.32 M sucrose, 1.0 mM NaHCO3, and 
1.0 mM dithiothreitol (pH 7.2).  The final synaptic vesicles were stored at -80 ºC until 
ready to use. 
Vesicular uptake of 5-HT was performed as described previously (Bartlett et al., 
1998).  Synaptic vesicles were resuspended in a buffer containing 5.0 mM MgCl2, 375 
mM sucrose, and 5.0 mM N-[2-hydroxyethyl]piperazine-N’-[ethanesulfonic acid] 
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(HEPES, pH 7.4) and maintained at 4 ºC.  Duplicate aliquots (1.0 mg protein/mL) of 
vesicles were preincubated for 5 min at 30 ºC.  The uptake was initiated with the addition 
of a concentrated stock solution (mixture of 5-HT and Pb-Ac, reserpine, or KNO3; 20 µL, 
30 ºC) to 7.815 µM [3H]-serotonin, which yielded a final assay mixture of 100 nM 5-HT, 
2.0 mM ATP, 4.0 mM MgCl2, 4.0 mM KCl, 300 mM sucrose, and 5.0 mM HEPES (pH 
7.4).  The concentrations of Pb-Ac used in the assay were 0.1µM, 0.5 µM, 1 µM, 5 µM, 
and 50 µM. The final mixtures (100 µL) were incubated for 1.5 min and terminated by 
the addition of 3.0 mL of ice cold 150 mM KCl.  Termination of uptake was followed by 
filtration through Millipore Hawp (25 mm diameter; 0.45 µm pore size).  The filters were 
washed twice more with 3.0 mL of the 150 mM KCl.  The filters were transferred to 5 
mL glass scintillation fluids.  Liquid scintillation fluid (3.5 mL; National Diagnostics) 
was added to the vials.  Radioactivity was quantified using a liquid scintillation counter 
(LSC, Beckman LS6500).  Residual radioactivity (filters without ATP) was subtracted to 
account for non-specific binding.  These nonspecific binding was quantified and 
accounted for by measuring [3H]-serotonin signal in the absence of ATP, and subtracted 
from all radioactive counts.  Protein concentrations of the assays were quantified using 
the Pierce BCA protein assay kit (bicinchoninic acid; Thermo Scientific, Rockford, IL).   
 
Statistical Analysis 
Data from the immunocytochemistry and HPLC analysis are expressed as mean ± 
SEM.  In the VMAT assay, data were expressed as nmol/min/mg protein mean ± SEM.  
Statistical analysis was performed using one-way analysis of variance (ANOVA) 
followed by Dunnett’s post hoc test; P < 0.05 was considered significant. 
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Results 
Pb exposure increases total 5-HT levels but does not change the degradation of 5-
HT in the brainstem of P21 mice 
At P21, the murine LSO has been shown to be heavily innervated by serotonergic 
axon terminals from the raphe (Thompson and Hurley, 2004).  Thus, it is possible that Pb 
may decrease synthesis, or increase degradation of 5-HT in the adult raphe, thereby 
resulting in decreased 5-HT immunoreactivity in the P21 LSO.  To determine whether Pb 
alters either synthesis or degradation of 5-HT within the entire brainstem (which contains 
the raphe nuclei) of P21 mice, 5-HT and 5-HIAA were measured in total brainstem 
fractions by HPLC analysis.  The brainstem was dissected into the ventral brainstem 
(VBS, which is enriched in auditory nuclei, including the LSO) and the dorsal brainstem 
(DBS, which contains no auditory nuclei, but instead contains most of the dorsal raphe 
nuclei), as described in the Methods.  Very low Pb increased 5-HT levels in both the VBS 
and DBS fractions compared to controls (Figure 13).  In contrast, 5HIAA levels and 5-
HT turnover (5-HIAA/5-HT) were not affected by Pb exposure, demonstrating that Pb 
does not affect degradation of 5-HT, and may increase the synthesis of 5-HT in the 
brainstem (Figure 13).   
These findings reveal that the Pb-induced decreases in 5-HT immunoreactivity 
within the P21 LSO are not the result of either decreased brainstem 5-HT levels or 
increased degradation of 5-HT.  In fact, total 5-HT levels within the brainstem increased 
with Pb exposure, even though 5-HT immunoreactivity within LSO was decreased.  
These results add support to the hypothesis that Pb exerts a developmental effect on the 
5-HT system within the LSO by modulating serotonergic innervation within the LSO.  
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Pb exposure does not affect SERT expression in the LSO of P21 mice 
In order to determine whether the Pb-induced decrease in 5-HT in the adult LSO 
is a result of impaired uptake into processes, the expression of SERT was characterized.  
Brainstem sections from P21 control and Pb-exposed mice were immunostained for 
SERT.  Both very low and low Pb exposure did not change SERT immunoreactivity 
within the LSO compared to controls (Figure 14).  Quantification of SERT 
immunostaining confirmed that Pb has no effect on SERT expression (Figure 14D), 
demonstrating that Pb induced decreases in 5-HT immunoreactivity at P21 is not 
correlated with altered SERT expression.   
 
Pb does not affect VMAT activity 
We have previously reported that Pb also decreases VMAT expression in the LSO 
of P21 mice (Fortune and Lurie, 2009), but it is not known whether Pb also impairs the 
function of VMAT.  Therefore, VMAT activity was measured in isolated synaptic 
vesicles of adult rats treated with various concentrations of Pb-acetate (Pb-Ac), ranging 
from 0.1 µM to 50 µM.   
These concentrations were chosen so the in-vitro assay mimicked the estimates of 
brain concentrations of Pb used in our in vivo mouse model.  Specifically, our Pb 
concentrations in vivo yielded blood Pb levels of 8.0 ± 0.4 µg/dL in very low Pb, and 
42.3 ± 1.97 µg/dL in low Pb exposed mice (Fortune and Lurie, 2009).  Based on these 
blood Pb levels, we then estimated brain Pb concentrations based on the previous studies 
of Widzowski and Cory-Slechta (1994) who reported that blood Pb levels of 17 µg/dL 
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Figure 13.  Pb exposure increases brainstem levels of 5-HT in P21 mice as measured by 
HPLC.  Pb exposure increases 5-HT levels both in the VBS (A) and DBS (B) fractions.  
Pb does not affect 5-HIAA levels or the 5-HT turnover (5HIAA/5-HT) in either fraction 
(A, B).  Graphs represent mean ± SEM.  *p<0.05; ANOVA with Dunnett’s post hoc test 
(n = 6). 
A Ventral brainstem-P21 
*	  
B Dorsal brainstem-P21 
*	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Figure 14.  Pb exposure does not affect SERT immunofluorescence (green) labeling 
within the LSO of P21 mice.  A-C: Immunoreactivity for SERT does not change with Pb 
exposure (B, C) compared to the no Pb control (A).  D:  Quantification of SERT 
immunostaining confirms that Pb does not affect SERT expression levels in the LSO.  
Graphs represent mean ± SEM.  ANOVA with Dunnett’s post hoc test (n = 5).  Scale bar 
= 50 µm. 
D	   	  	  	  	  SERT-­‐P21-­‐LSO	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and 38 µg/dL correspond to brainstem Pb levels of 0.1 µg/g wet tissue weight (0.330 µM 
Pb-Ac) and 0.48 µg/g wet tissue weight (1.582 µM Pb-Ac) (Widzowski and Cory-
Slechta, 1994).  Table 1 illustrates that Pb did not affect VMAT activity in any of the 
concentrations used compared to no Pb controls.   In contrast, the uptake of 5-HT was 
almost completely inhibited in synaptic vesicles treated with reserpine, a known VMAT 
inhibitor, and KNO3, a known VATPase inhibitor (Table 1).  These findings demonstrate 
that Pb does not acutely affect the function of VMAT.  
 
Pb changes the expression pattern of GAP-43 in the LSO of P21 mice 
 The findings that Pb increases 5-HT within the total brainstem and does not 
change either SERT expression or VMAT activity, lends support to our hypothesis that 
Pb exerts a developmental effect on the serotonergic system and produces changes in 
axonal aborization and synaptogensis that persist into adulthood.  We have previously 
shown that Pb modulates the expression of GAP-43 within the LSO of early postnatal 
mice (chapter I).  GAP-43 is a marker for axonal growth and plasticity (Illing et al., 
2000).  Within auditory brainstem nuclei, both the intensity of immunoreactivity as well 
as the staining pattern of GAP-43 is altered following injuries such as cochleotomy and 
acoustic trauma (Illing et al., 1997; Michler and Illing, 2002).  
Unlike other auditory brainstem nuclei where GAP-43 mRNA levels are high 
during the first postnatal week but gradually decrease and are almost entirely lost in the 
adult animal, LSO neurons are unique in that they continue to express high levels of 
GAP-43 mRNA into adulthood.  The persistence of GAP-43 indicates the plasticity 
potential of LSO neurons (Illing et al., 1999). 
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Table 1.  VMAT activity assay 
Compound Percent of Control  
0.1 µM Pb-Ac  81 ± 14.5 
0.5 µM Pb-Ac 99 ± 4.7 
1 µM Pb-Ac 113  
5 µM Pb-Ac 103 ± 4.7 
50 µM Pb-Ac 130 ± 8.4 
0.1 µM Reserpine  6 ± 2.3 
50 mM KNO3  18 ± 4.6  
 
Table 1.  Pb does not significantly alter the VMAT-mediated transport of 3H-serotonin 
into synaptic vesicles isolated from rat brains.  Data are presented as % of control (Mean 
± SE).  Reserpine, an inhibitor of VMAT, is used as a positive control for VMAT 
inhibition and does inhibit the activity of VMAT in this assay.  Similarly, KNO3, an 
inhibitor of VATPase, also inhibits the activity of VMAT.   
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We have also found that decreases in SYP are accompanied by decreased 
expression of GAP-43 in the Pb exposed LSO of early postnatal mice (Figure 10-12 in 
chapter I).  In order to determine whether Pb results in changes in GAP-43 in adult (P21) 
mice as well, control and Pb-exposed brainstem sections from P21 mice were 
immunostained for GAP-43.  Figure 15A illustrates that the control LSO contains a 
moderate amount of GAP-43 immunostaining that appears to be localized within 
distinctly delineated fibers and varicosities, presumably reflecting the presynaptic 
endings (Horvath et al., 1997).  Quantification of total GAP-43 staining in the LSO 
demonstrated that Pb exposure did not affect total intensity of GAP-43 staining compared 
to controls (Figure 15D).  However, the pattern of staining changed.  In the Pb treated 
mice, there was increased immunostaining within varicosities that likely represent 
synaptic boutons onto LSO neurons.  These varicosities (or boutons) were rather 
diffusely distributed, and the size of these varicosities was generally larger in the LSO of 
Pb exposed mice (Figure 15B, C).  The modulations in GAP-43 expression together with 
the known Pb-induced decreases in syaptophysin within LSO (Fortune and Lurie, 2009) 
further support the hypothesis that developmental Pb exposure produces permanent 
changes in synapse formation within the adult LSO.   
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Figure 15.  Pb exposure alters the staining pattern of GAP-43 immunolabeling (green) 
within the LSO of P21 mice.  A-C: GAP-43 Immunoreactive varicosities in the LSO are 
rather diffusely distributed, and the size of boutons is generally larger with Pb exposure 
(arrows in B, C) compared to control (A).  D: Quantification of SERT immunostaining 
shows that Pb does not affect total GAP-43 expression levels in the LSO.  Graphs 
represent mean ± SEM.  ANOVA with Dunnett’s post hoc test (n = 5).  Scale bar = 50 
µm. 
D	   GAP43-­‐P21-­‐LSO	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Pb increases 5-HT expression in the IC of P21 mice 
LSO neurons provide a major afferent input to the central nucleus of inferior 
colliculus (CNIC), contributing to the tonographically organized laminar formation 
within the IC (Thompson and Schofield, 2000).  In the rat IC, developmental processes 
that include axon collateralization and synapse formation occur predominately from birth 
to P11 (Kandler and Friauf, 1993), the same time period when LSO neurons transiently 
accumulate 5-HT.  Because we have shown that Pb delays the normal developmental 
uptake of 5-HT by LSO neurons, an intriguing possibility is that Pb could also affect the 
serotonergic system within the IC. 
Therefore, control and Pb exposed brainstem sections from P21 and P4 mice were 
immunostained for 5-HT.  P4 mice showed very little 5-HT immunostaining in the IC, 
and Pb exposure did not appear to change the levels of immunoreactivity (data not 
shown).  The 5-HT positive processes within the CNIC originate mainly from dorsal and 
median raphe in adult animal (Klepper and Herbert, 1991; Hurley et al., 2002) and we 
observed 5-HT immunoreactive processes in the P21 IC of control and Pb exposed mice 
(Figure 16).  Very low levels of Pb significantly increased 5-HT immunoreactivity within 
the LSO (Figure 16B, D) but low Pb exposure did not affect 5-HT immunoreactivity 
(Figure 16C).  This is very interesting, because Pb decreased 5-HT in the adult LSO, but 
increased 5-HT in the IC. 
 
Pb does not affect total IC levels of 5-HT and 5HIAA 
Levels of 5-HT and 5-HIAA were measured in the IC fractions of P21 mice by 
HPLC analysis in order to determine whether Pb affects 5-HT synthesis and/or  
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Figure 16.  Pb exposure increases 5-HT immunofluorescence (green) labeling in the IC 
of P21 mice.  A-C: Immunoreactivity for 5-HT in the IC increases with very low Pb 
exposure (B) compared to the no Pb control (A).  Low Pb exposure (C) does not result in 
changes in total 5-HT expression.  D:  Quantification of 5-HT immunostaining in the IC 
confirms a significant increase with very low Pb.  Graphs represent mean ± SEM.  
*p<0.05; ANOVA with Dunnett’s post hoc test (n = 7).  Scale bar = 50 µm. 
D	   	  	  	  	  5-­‐HT-­‐P21-­‐IC	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degradation within the IC.  Pb exposure did not affect 5-HT levels in the IC 
fractions compared to controls (Figure 17A).  In addition, 5HIAA levels and 5-HT 
turnover (5-HIAA/5-HT) were not affected by Pb (Figure 17B, C).  Thus, Pb did not 
acutely affect synthesis or degradation of 5-HT in the adult IC but did increase the 
number of 5-HT processes within the CNIC.  This argues for a developmental effect of 
Pb on the CNIC, perhaps involving permanent axonal rearrangements of 5-HT fibers.  
 
Pb does not affect SERT expression in the IC of P21 mice  
In order to confirm that the increase in 5-HT in the CNIC is not correlated with 
changes in SERT expression,  brainstem sections from P21 control and Pb-exposed mice 
were immunostained for SERT.  Both very low and low Pb did not change SERT 
immunoreactivity within the IC of P21 mice compared to controls (Figure 18), 
demonstrating that Pb induced increases in 5-HT expression in the P21 IC were not 
correlated with any changes in SERT expression.  Thus, Pb did not impact 5-HT re-
uptake, synthesis or degradation in the P21 IC.  
 
Pb increases VMAT2 expression in the IC of P21 mice 
Finally, Pb exposure has been shown to decrease VMAT2 expression in the LSO 
of P21 mice (Fortune and Lurie, 2009); thus it is possible that Pb also affects VMAT2 
expression in the IC.  To test whether Pb modulates the expression of VMAT2 within the 
IC, control and Pb exposed brainstem sections were immunostained for VMAT2.  Low 
Pb significantly increased immunoreactivity for VMAT2 in the CNIC of P21 mice 
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(Figure 19C, D), compared with controls (19A).  In contrast, very low Pb did not result in 
changes in VMAT2 expression (Figure 19B).   
It is of interest to note that Pb increased the number of 5-HT stained processes 
within the IC following very low level exposure, but there was increased density of 
VMAT2 (and presumably presynaptic terminals) at a different (low level) exposure.  
These findings suggest that Pb might have two different effects on axonal maturation at 
different doses during the period of IC development.  At very low levels (0.01 mM), Pb 
increases axon collateralization or alternatively, interfers with the retraction of 
serotonergic axonal processes within the IC.  In contrast, at higher doses (our low Pb 
dose, 0.1 mM), Pb may increase the number of axon terminal that contain VMAT2.   
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Figure 17.  Pb exposure does not change 5-HT levels in the inferior colliculus of P21 
mice as measured by HPLC analysis (A, C).  In addition, Pb does not change 5-HIAA 
levels or 5-HT turnover (5HIAA/5-HT) in the IC (B, C).  Graphs represent mean ± SEM.  
ANOVA with Dunnett’s post hoc test (n = 6). 
A	   5HT-­‐P21-­‐Inferior	  colliculus	  
B	   5HIAA-­‐P21-­‐Inferior	  colliculus	  
C	   5HIAA/5HT-­‐P21-­‐Inferior	  colliculus	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Figure 18.  Pb exposure does not alter SERT immunofluorescence (green) labeling 
within the IC of P21 mice.  A-C: Immunoreactivity for SERT in the IC does not change 
with Pb exposure (B, C) compared to the no Pb control (A).  D:  Quantification of the 
SERT immunostaining confirms that Pb has no effect on SERT labeling in the IC.  
Graphs represent mean ± SEM.  ANOVA with Dunnett’s post hoc test (n = 5).  Scale bar 
= 50 µm. 
D	       SERT-­‐P21-­‐IC	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Figure 19.  Pb exposure increases vesicular monoamine transporter 2 (VMAT2) 
immunofluorescence (green) labeling in the IC of P21 mice.  A-C: Immunoreactivity for 
VMAT2 in the IC increases with low Pb exposure (C) compared to no Pb control (A).  
Very low Pb exposure (B) does not result in changes in total VMAT2 expression.  D:  
Quantification of VMAT2 immunostaining in the IC confirms that the increase with low 
Pb is statistically significant.  Graphs represent mean ± SEM.  *p<0.05; ANOVA with 
Dunnett’s post hoc test (n = 7).  Scale bar = 50 µm. 
D	   	  	  	  	  VMAT2-­‐P21-­‐IC 
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Discussion 
The current study demonstrates that a Pb-induced decrease in 5-HT 
immunostaining within the P21 LSO is not the result of an acute effect of Pb on 5-HT 
metabolism.  Changes in the GAP-43 staining pattern in the LSO suggest that decreased 
5-HT and VMAT2 immunoreactivity is correlated with altered axonal arborization and 
synapse development in the LSO.  In addition, very low levels of Pb exposure increased 
5-HT immunoreactivity in the IC of P21 mice, suggesting that Pb may also affect the 
development of the IC.  Pb did not alter total IC levels of 5-HT and 5HIAA, and had no 
effect on SERT expression within the IC, suggesting that the Pb induced increase in 5-HT 
immunoreactive processes that is observed with very low Pb exposure is likely the result 
of changes in axonal arborization that occurs during development.  Interestingly, low 
levels of Pb exposure increased VMAT2 expression within the IC, suggesting that 
different doses of Pb might have two different effects on axonal maturation of the IC.  To 
our knowledge, this is the first evidence in vivo that differing doses of Pb affect different 
aspects of neuronal maturation in the same brain area.    
 
Effect of Pb on 5-HT processes in the LSO and IC 
5-HT functions as a regulatory factor for the brain development prior to the time 
when it plays a role as a neurotransmitter (Luo et al., 2003).  Alterations in 5-HT 
homeostasis during development have been shown to cause permanent changes in the 
fine wiring of neural connections in the brain and to result in abnormal behaviors that 
persist into adulthood (Mazer et al., 1997; Vataeva et al., 2007; Vitalis et al., 2007; 
Vataeva et al., 2008).  The most striking evidence of 5-HT induced mis-wiring of brain 
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connections comes from the somatosensory system, where “non-serotonergic” 
thalamocortical neurons transiently accumulate 5-HT during early postnatal development.  
Maintaining normal 5-HT levels in this system is critical for the proper formation of 
barrels that are the morphological substratum of the somatosensory cortical map, in 
which each of the barrels corresponds to the afferent thalamic axonal projection from one 
whisker to the somatosensory cortex (Gaspar et al., 2003).  Interestingly, these barrels are 
absent in the somatosensory cortex of MAOA k/o mice where brain 5-HT levels are 
increased up to 6-9 fold compared to wild type mice (Cases et al., 1996).  In contrast to 
the complete loss of barrel fields induced by excessive amounts of 5-HT, depletion of 5-
HT by pharmacological intervention results in barrel fields that are either smaller in size 
or are developmentally delayed (Blue et al., 1991; Bennett-Clarke et al., 1994; Turlejski 
et al., 1997).  Importantly, there seems to be a critical period for wiring in the 
somatosensory cortex, because MAOA inhibition during the first postnatal week only 
causes a disruption in the barrel field formation (Vitalis et al., 1998).   
In the auditory system, LSO neurons also transiently accumulate 5-HT most 
prominently during the first postnatal week (Cases et al., 1998; Thompson, 2006, 2008).  
During postnatal development, the transient expression of 5-HT precedes the auditory 
inputs from cochlear nucleus and is concomitant to the maturation of synapses and 
dendrites in the LSO.  The mature pattern of collateral branching of the afferents from the 
cochlear nucleus is established in the LSO during the period of E18 to P5 in rats (Kandler 
and Friauf, 1993; Friauf and Lohmann, 1999) with the refinement and pruning of 
dendrites of LSO neurons beginning at P4 (Rietzel and Friauf, 1998).  From these studies, 
it appears that maintence of proper extracellular concentrations of 5-HT through uptake 
89 
 
by SERT is necessary for the maturation of LSO synapses.  Therefore, continuous 
removal of 5-HT for an extended period of time through uptake into non-serotonergic 
LSO neurons (Chapter 1) limits the amount of 5-HT that is available for the appropriate 
maturation of synapses in the LSO. 
LSO neurons provide a major afferent input to the central nucleus of inferior 
colliculus (CNIC), contributing to the tonographically organized laminar formation 
within the IC (Schofield, 2006).  In the rat IC, developmental processes that include axon 
collateralization and synapse formation occur predominately from birth to P11 (Kandler 
and Friauf, 1993), the same time period when LSO neurons transiently accumulate 5-HT.  
However, IC neurons do not transiently take up 5-HT during development (data not 
shown) and so the increase in 5-HT positive processes in the IC following Pb exposure 
could be a secondary effect of Pb on the LSO.  
 
Effect of Pb on synaptogenesis in the LSO and IC 
In addition, Pb decreases the total immunostaining of synaptophysin (SYP) and 
VMAT2 and changes the staining pattern of GAP-43 in the adult LSO indicating that Pb 
alters synapse maturation within the LSO.  SYP is a component of the membrane of 
presynaptic vesicle, thus immunostaining is thought to label all presynaptic terminals.  
The current study demonstrates that Pb appears to decrease synaptogenesis in general, 
including monoaminergic synapses as measured by VMAT2 immunostaining, within the 
adult LSO.  In contrast, Pb resulted in increased VMAT2 staining in the CNIC, but did 
not change total SYP staining (data not shown).  This suggests that Pb specifically affects 
synaptogenesis of monoaminergic inputs into the IC and has little effect on other synaptic 
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connections.  We have found no significant changes in immunoreactivity for the vesicular 
glutamate transporter (VGLUT1) in the IC following Pb exposure (data not shown), 
further supporting the idea that the development of the monoaminergic system is 
specifically targeted by Pb in central auditory nuclei.  The fact that Pb did not affect 
immunostaining of SYP within the IC also indicates that Pb subtly impairs the precise 
organization of the topographic map in the IC, instead of causing a general increase or 
decrease in the total number of synapses.  Future studies that include a detailed 
morphological analysis of single axon arbors immunostained with 5-HT or other 
monoaminergic markers are necessary to test this possibility.   
 
Summary and Conclusion 
The results of the current study reveal that specific changes in 5-HT 
immunostaining within the LSO and IC are not associated with an acute effect of Pb on 
5-HT metabolism, suggesting that Pb may be affecting axonal arborization and synaptic 
maturation within these central auditory nuclei during development.  In addition, we 
found that Pb affected the pattern of GAP-43 and VMAT2 staining in the adult, further 
supporting the hypothesis that developmental Pb exposure has lasting effects on synaptic 
maturation that persist in the adult.  The fact that Pb increased the number of 5-HT 
immunoreactive processes within the IC, but decreased the number of these processes in 
the LSO further suggests that Pb modulates process arborization differentially in the two 
nuclei.  The mechanism for this remains to be elucidated, but differential effects of Pb on 
neurite outgrowth have been reported in vitro (Wang et al., 2008).  Our results also raise 
the intriguing possibility that different doses of Pb affect the IC differentially, with very 
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low doses increasing the number of 5-HT positive processes, and low Pb doses increasing 
synaptogenesis of monomaminergic neurons.  To our knowledge, this is the first evidence 
in vivo that differing doses of Pb modulate different aspects of neuronal maturation and it 
will be exciting to further elucidate this mechanism of action of Pb. 
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CHAPTER III. 
LOW LEVELS OF Pb RESULTS IN DECREASED 5-HT EXPRESSION IN 
THALAMOCORTICAL NEURONS AT THEIR AXON TERMINALS AND 
DECREASES 5-HT LEVELS IN THE FOREBRAIN OF EARLY POSTNATAL 
MICE  
 
Abstract  
Low-level Pb exposure is a risk factor for cognitive and behavioral dysfunctions 
including learning disability and ADHD.  The cellular mechanism that underlies these 
Pb-induced dysfunctions, especially during brain development, is incompletely 
understood.  During the early peri and postnatal period of development, certain “non-
serotonergic” sensory neurons, including LSO neurons in the auditory system and 
thalamocortical neurons in the somatosensory system, transiently take up 5-HT from 
extracellular environment.  This is thought to be a way to maintain appropriate levels of 
extracellular 5-HT that is important for the development of these sensory systems.  We 
have previously reported that low-level Pb exposure results in a delay in the uptake of 5-
HT by early postnatal LSO neurons, and that this delay is correlated with altered synaptic 
maturation  (chapter I), suggesting that sensory neurons that take up 5-HT transiently 
could be a specific target for Pb.  The current study was undertaken to determine whether 
Pb has a similar effect on the transient expression of 5-HT by the thalamocortical neurons 
of early postnatal mice.  Mice were exposed to very low Pb (0.01mM) or low Pb 
(0.1mM) throughout gestation and until postnatal day 4 (P4), or P8.  Forebrain sections 
from postnatal control and Pb-exposed mice were immunostained for 5-HT and levels of 
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5-HT and 5HIAA were measured by HPLC analysis.  To examine the dorsal raphe, 
brainstem sections from postnatal control and Pb-exposed mice were immunostained for 
5-HT and TPH.  We found that Pb decreases immunoreactivity for 5-HT in the 
thalamocortical axon terminals (TCAs) in the area of somatosensory cortical barrel field.  
In addition, total forebrain levels of 5-HT and 5HIAA decrease with Pb as does 5-HT 
immunoreactivity within the DR.  Finally, Pb increases TPH expression in the DR, 
perhaps as a compensatory mechanism.  These findings demonstrate that the effect of Pb 
is not restricted to the TCAs, but appears to have a widespread impact on the forebrain 5-
HT system. 
 
Introduction 
Lead (Pb) is a highly neurotoxic agent that causes functional and structural 
abnormalities in the brain (Canfield et al., 2003).  The U.S. Environmental Protection 
Agency (EPA) estimates that 430,000 American children between 1 and 5 years old have 
blood Pb levels at or above 10 µg/dL (EPA, 2004), and blood levels of 10 µg/dL are 
thought to be a threshold for childhood cognitive deficits (Landrigan, 2000).  The 
developing central nervous system (CNS) has long been recognized as a primary target 
for environmental Pb exposure (Landrigan and Todd, 1994; Moreira et al., 2001), 
therefore Pb could impact critical stages of brain development.  Pb has been shown to 
induce permanent neurological changes when exposure occurs during the first 6 years of 
life in children (the Centers for Disease Control, CDC, 1991), indicating that this heavy 
metal has a profound effect on CNS development.  Currently, 10 µg/dL is the CDC limit 
of concern for childhood blood Pb levels (CDC, 1991).  However, recent data suggests 
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that blood Pb levels lower than 10 µg/dL can produce deficits in neurobehavioral-
cognitive performances including decline in IQ, and attention deficit hyperactivity 
disorder (ADHD) (Bellinger and Bellinger, 2006; Braun et al., 2006; Bellinger, 2008).  
The cellular mechanism that underlies these Pb-induced cognitive and 
neurobehavioral dysfunctions, especially during early development, is incompletely 
understood.  We have previously reported that low-level Pb exposure during development 
decreases the immunoreactivity of serotonin (5-HT) and the vesicular monoamine 
transporter 2 (VMAT2) in brainstem auditory nuclei, providing a link between Pb 
exposure and the serotonergic system (Fortune and Lurie, 2009).  Indeed, developmental 
Pb exposure has been shown to alter brain levels of 5-HT and a major metabolite of 5-
HT, 5-hydroxyindole-3-acetic acid (5-HIAA), in various brain regions (Cupo and 
Donaldson, 1988; Antonio et al., 1996; Antonio and Leret, 2000; Devi et al., 2005).  5-
HT functions as a growth regulatory factor in the brain during development, and 
embryonic or neonatal depletion of 5-HT results in impaired synaptogenesis and 
abnormal behaviors that persist into adulthood (Mazer et al., 1997; Vataeva et al., 2007; 
Vitalis et al., 2007; Vataeva et al., 2008).  Thus, Pb could have a lasting impact on the 
brain by modulating 5-HT during critical periods of CNS development. 
The rodent somatosensory cortex has been a preferred model of choice to test the 
effect of 5-HT on brain development, owing to its distinct barrel-like pattern composed of 
afferent thalamocortical axon terminals (TCAs) and cortical layer IV neurons.  
Furthermore, these non-serotonergic TCAs transiently take up 5-HT from extracellular 
sources during the critical period of barrel field formation through SERT, a high affinity 
5-HT transporter, which is also transiently expressed in the TCAs (Gaspar et al., 2003).  
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The cortical barrel fields (BFCx) emerge over the first postnatal week through axon 
collateral remodeling, and precise regulation of 5-HT levels in thalamocortical neurons is 
important for the proper formation of the BFCx (Rebsam et al., 2002; Gaspar et al., 2003; 
Luo et al., 2003).  Depletion of 5-HT has been shown to produce a delay in barrel pattern 
maturation (Blue et al., 1991; Osterheld-Haas and Hornung, 1996) as well as a reduction 
in barrel field area (Bennett-Clarke et al., 1994; Persico et al., 2000). 
 Interestingly, in rats exposed to Pb from P1 through P10, the total area of the 
barrel field in primary somatosensory cortex decreases with increasing doses of Pb 
(Wilson et al., 2000).  This raises the intriguing possibility that the Pb induced deficits in 
the development of the BFCx in rodents are associated with Pb induced alterations in 5-
HT levels in the somatosensory cortex.  However, the effect of Pb on the transient uptake 
of 5-HT by the thalamocortical neurons has not been examined. 
The current study was undertaken to determine the effect of developmental Pb 
exposure on the transient presence of 5-HT within the TCAs in early postnatal mice.  
Forebrain sections from postnatal control and Pb-exposed mice were immunostained for 
5-HT and levels of 5-HT and 5HIAA were measured by HPLC analysis.  To test whether 
Pb exposure affects the synthesis of 5-HT by the dorsal raphe nuclei (DR), a major 
serotonergic input to the somatosensory cortex, brainstem sections from postnatal control 
and Pb-exposed mice were immunostained for 5-HT and tryptophan hydroxylase (TPH), 
a rate limiting enzyme for 5-HT synthesis.  We found that Pb exposure decreases 
immunoreactivity for 5-HT in the TCAs of Pb exposed mice at P4 compared to controls.  
In addition, total forebrain levels of 5-HT and 5HIAA decrease with Pb exposure as does 
5-HT immunoreactivity within the DR.  Finally, Pb increases TPH expression in the DR.  
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These findings demonstrate that a Pb-induced change in 5-HT levels during the early 
postnatal period is correlated with decreased 5-HT immunostaining in TCAs.  
 
Materials and Methods 
Chronic lead exposure to CBA/CaJ mice 
 Breeding pairs of CBA/CaJ mice were obtained from the Jackson Laboratory (Bar 
Harbor, MA).  Mice were maintained in microisolator units and kept in the University of 
Montana specific pathogen free animal facility.  Cages, bedding, and food were sterilized 
by autoclaving and mice were handled with aseptic gloves.  Mice were allowed food and 
water ad libitum.  All animal use was in accordance with NIH and University of Montana 
IACUC guidelines.  Breeding pairs of CBA mice were randomly assigned to three groups 
having unlimited access to water (pH 3.0) containing 0 mM (control), 0.01 mM (very 
low) or 0.1 mM (low) lead acetate.  Offspring were exposed to lead throughout gestation 
and through the dam’s milk until sacrifice on postnatal day 4 (P4), or day 8 (P8).  These 
concentrations of Pb yield blood Pb levels of 8.0 ± 0.4 µg/dL in very low Pb, and 42.3 ± 
1.97 µg/dL in low Pb P21 mice (Fortune and Lurie, 2009).   
 
Tissue preparation for Immunohistochemistry 
 Mice were deeply anesthetized using 2’,2’,2’-tribromoethanol (TBE) and perfused 
transcardially with 4% Na-periodate-lysine-paraformaldehyde fixative (PLP, final 
concentrations 0.01M sodium periodate, 0.075M lysine-HCl, 2.1% paraformaldehyde, 
0.037M phosphate).  Brains were removed and post-fixed in PLP overnight at 4°C, rinsed 
3 times for 10 minutes each in phosphate buffered saline (PBS) and transferred to a 20% 
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sucrose solution in PBS for 2 days at 4°C.  Finally, brains were transferred to a 1:1 
mixture of a 20 % sucrose solution in PBS and Optimal Cutting Temperature (O.C.T.) 
compound (Sakura Finetek, Torrance, CA) for 1-2 days at 4°C.  Brains were embedded 
into 1.5 cm square embedding cups filled with O.C.T. compound, and then frozen in dry 
ice and 100% ethanol and stored at -20°C.  Ten micron tissue sections were cut on a 
Thermo Shandon Cryotome Cryostat (Thermo Shandon, Pittsburg, PA) and a one in three 
series was collected for each brain.    
 
Immunohistochemistry   
 Sections were thawed to room temperature and rinsed in PBS three times for 10 
minutes each.  Sections were then permeabilized for 30 minutes in 0.5% Triton X-100 in 
PBS and blocked for 30 minutes with either 4% normal goat or donkey serum (Vector 
Laboratories, Burlingame, CA) in PAB (1% sodium azide, 0.5% bovine serum albumin in 
PBS) and incubated with primary antibody for overnight in a humid chamber at 4°C.  The 
sections were rinsed in PBS three times for 10 minutes each and incubated with the 
appropriate secondary antibody (Alexa Fluor-488 anti-rabbit or Alexa Fluor-488 anti-
sheep, Invitrogen, Grand Island, NY) in PAB for one hour at room temperature in the 
dark.  Sections were then rinsed in PBS followed by distilled water and coverslipped with 
FluorSaverTM (Calbiochem®, San Diego, CA) and stored at 4°C.  The primary 
antibodies used for immunohistochemitry were as follows:  rabbit polyclonal anti-5-HT 
(1:10,000), sheep polyclonal anti-TPH (1:500). 
 
Antibodies  
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The rabbit polyclonal against serotonin (5-HT) was raised in rabbit against 
serotonin coupled to bovine serum albumin with paraformaldehyde (Cat. No. 20080, 
ImmunoStar Inc., Hudson, WI).  No cross-reactivity of serotonin antisera was seen with 
5-hydroxytrytophan, 5-hydroxyindole-3-acetic acid, and dopamine (manufacturer’s 
specifications).  This 5-HT antibody labels our mouse forebrain and brainstem sections in 
a staining pattern virtually identical to that of other studies using the same antiserum to 
label the mouse raphe nuclei (Thompson 2006), and the mouse somatosensory cortex 
immunostained with a different rat monoclonal antibody against 5-HT (SeraLab; Lebrand 
et al., 1996).  This antibody has also been characterized in our mouse system (Fortune 
and Lurie, 2009).  In addition, preadsorption with the 5-HT/bovine serum albumin (BSA) 
conjugate protein (20 µg/ml, Cat. No. 20081, ImmunoStar Inc., Hudson, WI) eliminates 
all immunoreactivity, whereas preadsorption with BSA does not affect immunostaining.   
 The sheep polyclonal antibody against tryptophan hydroxylase (TPH) was raised 
in sheep against recombinant rabbit tryptophan hydroxylase, isolated as inclusion bodies 
from E.coli (Cat. No. AB1541, Millopore, Temecula, CA).  This TPH antibody labels our 
mouse brainstem sections in a staining pattern virtually identical to that observed in 
mouse superior olive and raphe nuclei (Thompson and Thompson, 2008). 
 
Tissue Imaging and analysis 
All fluorescent slides were viewed at 60x objective using an Olympus FV 1000 
Fluoview Confocal microscope.  Quantitative analysis for immunostaining was 
performed as previously described (Fortune and Lurie, 2009).  Briefly, images were 
collected and then converted from color tiff files to black and white 12-bit tiff files, and 
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the integrated optical density (IOD) of the immunostaining was measured using 
MediaCybernetics Image-Pro software (Bethesda, MD).  IOD measurements were used 
for quantification of immunostaining because it analyzes both the area of immunostained 
tissue that met threshold as well as the intensity of the immunostaining.  A threshold of 
immunostaining in control (No Pb) animals was set for each antibody such that all 
immunoreactivity met threshold, and was used as a comparison with the Pb treatment 
groups.  Immunostaining in thalamocortical axon terminals within the area of cortical 
barrel fields and dorsal raphe nuclei in control and Pb-exposed mice were then quantified 
and averaged.  5-HT immunostaining has been used to visualize thalamocortical axon 
terminals within the cortical barrels during the postnatal period (Cases et al., 1996; 
Lebrand et al., 1996; Rebsam et al., 2002).  The 5-HT positive thalammocortical afferents 
have been shown to reach the cortex early in the embryonic period, and start to form 
characteristic clusters of cells that constitute barrels at P3.  The clusters become more 
clearly defined by P7, with one thalamocortical axon cluster confined to only one barrel 
(Rebsam et al., 2002).  This 5-HT staining then subsequently decreases and completely 
disappears by postnatal week two (Cases et al., 1996; Lebrand et al., 1996).  Unlike the 
horizontal section where the distinct columnar structure of barrels is visible, the number 
and size of barrels varies across the barrel field in the coronal sections that were used in 
the current study.  Therefore, 3-4 random barrels from each of the left and right primary 
somatosensory cortices from a single coronal section were chosen for analysis, and the 
IOD from each individual barrel was measured and averaged.  We consequently 
measured intensity of 5-HT immunostaining rather than the total area of staining.  A total 
of 36-40 individual barrels from each mouse were measured.   Statistical differences in 
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immunostaining between control and Pb-exposed mice were analyzed using GraphPad 
Prism 4.0 software (GraphPad Software, La Jolla, CA). 
 
Sample preparation for HPLC analysis  
 Mice from control and Pb exposed groups were decapitated at P4.  Brains were 
quickly dissected and the hindbrain (or brainstem) was removed with a coronal cut 
separating dorsally the superior and inferior colliculus.  After dissection, the remaining 
basal cerebral cortex was gently removed from the separated hindbrain fraction under the 
dissecting microscope, and added to the forebrain fraction.  Forebrain fractions were 
immediately weighed, and quickly frozen in the liquid nitrogen.  Each forebrain fraction 
was homogenized in 500 µl of 0.05 M perchloric acid (PCA; containing 30 ng/ml 3,4-
dihydrobenzylamine (DBA) as an internal standard) solution (Branson Sonifier 150, 
Branson, Danbury, CT), and stored at -20 ºC until ready to use.  
 
RP-HPLC analysis of 5HT/5HIAA 
 5-HT and its metabolite, 5-hydroxyindole-3-acetic acid (5-HIAA) levels were 
measured using reverse phase high performance liquid chromatography (RP-HPLC) with 
electrochemical detection.  The homogenates were centrifuged at 14,000 x g for 20 min at 
4ºC and the supernatants filtered through a Millex® hydrophilic LCR (PTFE) 0.45 um 
filter (Millipore, Bedford, MA).  Sample filtrates were loaded into autosampler vials and 
were placed into an ESA Model 5 autosampler (ESA, Chelmsford, MA).  An OmniSpher 
5 C18 chromatographic column (Varian Inc., Lake forest, CA) with a length of 25 cm and 
an internal diameter of 4.6 mm was used to separate analytes.  The mobile phase 
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consisted of water:acetonitrile (9:1, vol/vol) containing 0.15 M monochloroacetic acid, 
0.12 M sodium hydroxide, 0.6 mM EDTA and 1.30 mM sodium octyl sulfate, and the pH 
was adjusted to 3.2 with glacial acetic acid.  A constant flow rate of 1ml/min was 
maintained and the column effluent was analyzed with a Model 5600A ESA CoulArray® 
electrochemical detector (ESA, Chelmsford, MA).  Potentials of the three ESA Model 
6210 four channel electrochemical cells, placed in series, were as follows: (channels 1 
through 5)-50, 0, 25, 100, 200 mV, (6 through 12) 300 mV.  5-HIAA and 5-HT were 
monitored at 200 mV.  Peak area ratios were used to calculate 5-HT and 5-HIAA levels 
from a calibration curve (peak area of analyte/ peak area of DBA).   
 
Statistical Analysis 
Data are expressed as mean ± SEM and were analyzed by using a one-way 
analysis of variance (ANOVA) followed by Dunnett’s post hoc test; P < 0.05 was 
considered significant. 
 
Results  
Pb exposure decreases 5-HT immunostaining in developing thalamocortical axon 
terminals in the BFCx 
In order to determine whether developmental Pb exposure affects the normal 
uptake of 5-HT by thalamocortical axon terminals (TCAs) in early postnatal ages, control 
and Pb-exposed forebrain sections from postnatal day (P) 4 and P8 were immunostained 
for 5-HT.  In P4 control mice, distinct clusters of 5-HT immuno-positive TCAs were 
observed in the area of the somatosensory barrel field cortex (BFCx) (Figure 20A).  Both 
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the very low and low Pb exposure significantly decreased 5-HT immunoreactivity in the 
TCAs (Figure 20B-D) compared with control (Figure 20A).  No 5-HT immuno-positive 
thalamocortical neuronal cell bodies were observed (data not shown) confirming the 
results of others who have not found 5-HT positive thalamic cell bodies in wild type mice 
(Cases et al., 1998; Donovan et al., 2002). 
By P8, a more defined aggregate of TCAs was observed in the BFCx as 
delineated by 5-HT immunoreactivity (Figure 21A).  Very low levels of Pb resulted in 
significantly less 5-HT staining in the TCAs (Figure 21B) compared with control (Figure 
21A, D).  Low levels of Pb, in contrast, produce significantly more 5-HT staining in the 
TCAs compared to controls (Figure 21C, D).  Thus the two different doses of Pb have a 
differing impact on 5-HT in the TCAs. 
Taken together, these findings demonstrate that at very low levels, Pb appears to 
decrease the normal developmental uptake of 5-HT by the TCAs in the somatosensory 
cortical barrel field area.  It will be of interest to determine whether very low Pb exposed 
TCAs continue to express 5-HT  beyond P10-P14, when TCAs normally lose the ability 
to take up 5-HT into the cell body.   
 
Pb decreases total 5-HT and 5HIAA levels in the forebrain  
 To determine whether these observed Pb-induced alterations in 5-HT 
immunostaining are correlated with changes in either synthesis or degradation of 5-HT 
within the forebrain, levels of 5-HT and a major metabolite of 5-HT, 5-hydroxyindole-3-
acetic acid (5-HIAA), were measured in crude forebrain fractions of P4 mice by HPLC 
analysis.  Both the very low and low levels of Pb significantly decreased forebrain levels 
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of 5-HT and 5HIAA compared to controls (Figure 22A, B), suggesting that Pb could be 
decreasing 5-HT synthesis.  5-HT turnover (5-HIAA/5-HT) was not changed by Pb, 
demonstrating that Pb does not modulate the degradation of 5-HT in the forebrain (Figure 
22C).  The HPLC analysis demonstrated that the Pb-induced decreases in the transient 
accumulation of 5-HT by TCAs are indeed correlated with decreases in forebrain levels 
of 5-HT.  Furthermore, these findings also revealed that the effect of Pb is not restricted 
to the TCAs, but appears to have a widespread impact on the forebrain 5-HT system.  
	  
Pb decreases immunoreactivity for 5-HT in the Dorsal Raphe nuclei 
 Because Pb decreased 5-HT levels in the forebrain, we examined whether Pb also 
decreases 5-HT immunoreactivity in the Dorsal Raphe (DR), a major serotonergic input 
to the cerebral cortex, including the somatosensory cortex (Vitalis and Parnavelas, 2003).  
Brainstem sections (which contain the DR region) from control and Pb exposed mice 
were immunostained for 5-HTin P4 and P8 mice.  In P4 mice, Pb resulted in significant 
decreases in 5-HT immunolabeling in	  the DR (Figure 23B, C).  Quantification of 5-HT 
immunolabeling demonstrated that the staining intensity of 5-HT in very low Pb exposed 
mice was significantly decreased compared to control mice (Figure 23D).  In P8 mice, Pb 
showed an increasing trend of 5-HT expression in the DR, but these changes were not 
statistically significant (Figure 24).  	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Figure 20.  Pb exposure decreases 5-HT immunofluorescence (green) labeling in the area 
of the somatosensory cortical barrel fields (BFCx) in postnatal day (P) 4 mice.  A-C: 
Both the very low (B) and low (C) Pb exposure decreases 5-HT expression in the BFCx 
compared to control mice (A).  D: Quantification of 5-HT immunostaining in the BFCx 
confirms this decrease is statistically significant in Pb exposed mice.  Graphs represent 
mean ± SEM.  *p<0.05; ANOVA with Dunnett’s post hoc test (n = 6).  Scale bar = 30 
µm. 
D	   5HT-­‐P4-­‐BFCx	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Figure 21.  Pb exposure alters 5-HT immunofluorescence labeling (green) in the region 
of the somatosensory cortical barrel fields (BFCx) in P8 mice.  A-C: Very low Pb 
exposure (B) decreases 5-HT expression in the BFCx compared to control mice (A).  In 
contrast, low Pb exposure (C) increases 5-HT expression in the BFCx.  D: Quantification 
of 5-HT immunostaining in the BFCx confirms these changes are statistically significant.  
Graphs represent mean ± SEM.  *p<0.05; ANOVA with Dunnett’s post hoc test (n = 6).  
Scale bar = 30 µm. 
D	   5HT-­‐P8-­‐BFCx	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Figure 22.   Pb exposure decreases total forebrain levels of 5-HT and 5HIAA in P4 mice.  
A, B: Total brainstem levels of 5-HT (A) and 5HIAA (B) decreases with Pb exposure in 
P4 mice.  C: 5-HT turnover ratio (5HIAA/5-HT) does not change with Pb exposure. 
Graphs represent mean ± SEM.  *p<0.05; ANOVA with Dunnett’s post hoc test (n = 5). 
C
\ 
5HIAA/5HT-­‐P4-­‐forebrain	  
A	   5HT-­‐P4-­‐forebrain	  
* * 
B	   5HIAA-­‐P4-­‐forebrain	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Figure 23.  Pb exposure decreases 5-HT immunofluorescence labeling (green) in the 
dorsal raphe (DR) at P4 mice.  A-C: Both the very low Pb (B) and low (C) Pb exposure 
decreases 5-HT expression in the DR compared to no Pb control (A).  D: Quantification 
of 5-HT immunostaining in the DR confirms that decrease is statistically significant in 
very low Pb exposed mice.  Graphs represent mean ± SEM.  *p<0.05; ANOVA with 
Dunnett’s post hoc test (n = 6).  Scale bar = 30 µm. 
5HT-­‐P4-­‐Dorsal	  Raphe	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Figure 24.  Pb does not affect 5-HT expression levels in the DR at P8 mice.  Both the 
very low Pb (B) and low (C) Pb dose do not significantly change 5-HT 
immunofluorescent labeling (green) compared to controls (A).  Quantification of the 
immunostaining (D) confirms that Pb has no significant effect on 5-HT staining in the 
DR.  Graphs represent mean ± SEM.  ANOVA with Dunnett’s post hoc test (n = 6).  
Scale bar = 30 µm. 
5HT-­‐P8-­‐Dorsal	  Raphe	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Pb increases immunoreactivity for TPH in the Dorsal Raphe nuclei 
 To examine whether the Pb induced decreases in 5-HT levels in the DR and 
forebrain are correlated with altered synthesis of 5-HT by raphe neurons, brainstem 
sections from control and Pb exposed mice were immunostained for tryptophan 
hydroxylase (TPH), a rate limiting enzyme in 5-HT synthesis.  Pb exposure resulted in 
significant increases of TPH immunolabeling in the DR of both P4 (Figure 25) and P8 
(Figure 26) mice.  Quantification of TPH staining in the DR demonstrated that the 
staining intensity for TPH in the low Pb exposed mice at P4 (Figure 25D) and in the very 
low and low Pb exposed mice at P8 (Figure 26D) was significantly increased compared 
to control mice.  The increase in TPH immunostaining suggests a compensatory response 
by DR neurons to Pb-induced decreases in 5-HT.  However, these results are puzzling in 
light of the fact that Pb did not seem to affect degradation of 5-HT (Figure 22C).  It could 
be that Pb decreases the function of TPH and therefore more TPH is synthesized to 
compensate for impaired activity of the enzyme.  Further studies are needed to fully 
define the effect of Pb on TPH activity.   
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Figure 25.  Pb increases TPH expression levels (green) in the DR at P4 mice.  A-C: Very 
low Pb shows an increasing trend of TPH immunostaining (B) while the low (C) Pb 
exposure significantly increases TPH immunostaining in the DR compared to control (A).  
D: Quantification of TPH immunostaining.  Graphs represent mean ± SEM.  *p<0.05; 
ANOVA with Dunnett’s post hoc test (n = 6).  Scale bar = 30 µm. 
TPH-­‐P4-­‐Dorsal	  Raphe	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Figure 26.  Pb increases TPH expression levels in the DR at P8 mice.  A-C: Both the 
very low Pb (B) and low (C) Pb exposure increases TPH immunostaining in the DR 
compared to control (A).  D: Quantification of TPH immunostaining in the DR confirms 
that increase is statistically significant.  Graphs represent mean ± SEM.  *p<0.05; 
ANOVA with Dunnett’s post hoc test (n = 6).  Scale bar = 30 µm.	  	  	  	  	  	  
TPH-­‐P8-­‐Dorsal	  Raphe	  
112 
 
Discussion 
The current study demonstrates that Pb decreased 5-HT immunoreactivity in the 
TCAs in the region of the BFCx during the early postnatal period (P4 and P8).  This 
decreased immunoreactivity for 5-HT in the TCAs is correlated with decreased 5-HT 
immunostaining in the DR and the entire forebrain.  Pb also increased TPH expression in 
the DR, indicating that this could be a compensatory response by DR neurons to Pb-
induced decreases in 5-HT.  
 
Depletion of 5-HT by Pb exposure  
The findings of the current study demonstrating decreases in 5-HT in the DR and 
forebrain confirm other studies that show an effect of Pb on 5-HT metabolism.  For 
example, when rats are exposed to Pb-Ac (300 mg/L; blood Pb 17.79 ± 0.4 µg/dL) from 
gestation through P5, both 5-HT and 5-HIAA levels decrease, and increases in 5-HT 
turnover (5-HIAA/5-HT) are observed in the entire brain (Antonio et al., 1996).  When 
the same concentration of Pb-Ac (300 mg/L) is used to expose rats for a longer period 
(from gestation through P12; blood Pb 29.32 ± 8.15 µg/dL) Pb decreases 5-HT and 5-
HIAA in the hippocampus, and decreases 5-HT without affecting 5-HIAA levels in the 
hypothalamus and cerebellum (Antonio and Leret, 2000).  Our Pb concentrations in vivo 
yield blood Pb levels of 8.0 ± 0.4 µg/dL in very low Pb, and 42.3 ± 1.97 µg/dL in low Pb 
exposed mice at P21 (Fortune and Lurie, 2009) and are in a similar range to these studies.  
  The mechanism underlying Pb induced changes in 5-HT levels is poorly 
understood.  The current study shows that Pb increases TPH expression in the DR, with 
no changes in 5-HT degradation, suggesting that Pb may interfere with 5-HT synthesis.  
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In the CNS, 5-HT is synthesized exclusively in neurons of the rostral (B6-B9; 
corresponding to the dorsal and median raphe nuclei) and caudal (B1-B5; corresponding 
to the raphe pallidus, magnus, obscures, and pontis) raphe nuclei (Gaspar et al., 2003).  
TPH is an initial, rate-limiting enzyme of 5-HT synthesis, responsible for converting 
tryptophan into 5-hydroxytryptamine, and TPH gene expression has shown to be 
regulated by 5-HT levels.  For example, depletion of 5-HT in rat brain by p-
chlorophenylalanine (PCPA), a potent and specific inhibitor of TPH, has been shown to 
produce a rapid reduction in TPH activity followed by increased TPH mRNA expression 
in the raphe and hypothalamus (Park et al., 1994).  Similarly, lesioning of serotonergic 
neurons by 5,7-dihydroxytryptamine (DHT) also has been shown to increase TPH mRNA 
expression in the raphe (Bendotti et al., 1990).  Therefore, the results of the present study 
showing increased TPH expression in the DR following Pb exposure appears to be a 
compensatory response to Pb-induced decreases in 5-HT levels.  In addition, the Pb-
induced decreases in 5-HT in the DR seems to be transient, because 5-HT levels in the 
DR recover to normal levels by P8, and we also observed that DR 5-HT levels do not 
change with Pb exposure in P21 mice (data not shown).  To our knowledge, this is the 
first study demonstrating increased TPH expression in the DR with developmental Pb 
exposure.   
The mechanism by which Pb initially produces decreases in 5-HT and 5HIAA 
levels in the P4 forebrain remains to be elucidated.  Previous studies have shown that 
reductions in 5-HT levels are correlated with increased 5-HT degradation following Pb 
exposure (Antonio et al., 1996), but we did not observe any changes in the degradation of 
5-HT.  However, our study uses mice instead of rats and we analyzed the forebrain region 
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only as opposed to the entire brain that was analyzed by Antonio et al, 1996. One 
possible explanation for the Pb induced decreases in the 5-HT and 5HIAA observed in 
current study is that Pb could inhibit the function of TPH and therefore more TPH is 
synthesized to compensate for impaired activity of the enzyme.  Further studies are 
necessary to define the effect of Pb on TPH activity.   
 
Functional implications of Pb induced decreases in 5-HT levels in early cortical 
development  
Serotonergic neurons are generated early in development, on embryonic day (E) 
12 to 15 in the rat (Gaspar et al., 2003).  One day after their generation, raphe neurons are 
able to synthesize 5-HT and begin to send axons towards the telencephalon.  Thus the 
serotonergic raphe neurons and their processes play a role in early cortical development 
by regulating diverse events such as proliferation, migration, differentiation, and 
synaptogenesis of cortical neurons (Vitalis and Parnavelas, 2003).  In the somatosensory 
barrel field cortex, “non-serotonergic” thalamocortical neurons have been shown to 
accumulate 5-HT through transient expression of the SERT transporter during early 
development, and precise regulation of 5-HT levels is critical for the proper formation of 
cortical barrel fields (Cases et al., 1996; Cases et al., 1998; Lebrand et al., 1998; Vitalis et 
al., 2002).  For example, in MAO k/o mice, where brain 5-HT levels are 6-9 fold higher 
than wild type mice during the first few postnatal weeks, barrels are not formed, as the 
clustering of both the thalamocortical axons and the cortical granular neurons around 
thalamocortical axon endings are disrupted (Cases et al., 1995; Lebrand et al., 1996; 
Vitalis et al., 1998; Upton et al., 1999).  In contrast to the complete loss of barrel fields 
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induced by excessive amounts of 5-HT, depletion of 5-HT by p-chloramphetamine (PCA) 
or DHT results in barrel fields that are either smaller in size or are developmentally 
delayed, but does not completely prevent the normal pattern of barrel field formation 
(Blue et al., 1991; Bennett-Clarke et al., 1994; Turlejski et al., 1997).  In addition to the 
effect on barrel field formation, depletion of 5-HT has also been shown to affect cortical 
maturation by reducing both dendritic arborization and the complexity of the pyramidal 
neurons of layer III and V in the somatosensory cortex and delaying incorporation of 
interneurons into the cortical plate (Vitalis et al., 2007).  Thus, depletion of 5-HT appears 
to impair cortical development in general, and is not restricted to a specific effect on 
thalamocortical neurons that transiently take up 5-HT (Persico et al., 2000; Gaspar et al., 
2003; Luo et al., 2003).  In the current study, we found that Pb decreases 5-HT levels in 
the DR and forebrain fractions, and decreases the transient uptake of 5-HT by 
thalamocortical axons.  These results suggest that Pb could delay cortical maturation 
including the formation of somatosensory cortical barrel fields.  In support of this, low 
levels of Pb exposure (1-31 µg/dL) from P1 through P10 in rats have been shown to 
decrease the area of cortical barrel field with increasing doses of Pb (Wilson et al., 2000).  
Future studies, including a detailed morphometric analysis of barrel field pattern and size 
are needed to confirm that the Pb induced deficits in the development of the BFCx in 
rodents are associated with Pb induced alterations in 5-HT levels in the somatosensory 
cortex. 
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Summary and Conclusion 
The current study demonstrates that Pb exposure decreased the uptake of 5-HT by 
TCAs during a critical period of cortical development.  Pb also decreased 5-HT levels in 
the forebrain and dorsal raphe (DR), suggesting that Pb may delay cortical development 
in general, and is not restricted to a specific effect on thalamocortical neurons.  Pb also 
increased TPH expression in the DR with no changes in 5-HT degradation, suggesting 
that Pb might inhibit the function of TPH resulting in an upregulation of TPH synthesis in 
order to compensate for impaired activity of the enzyme.  To our knowledge, this is the 
first study to demonstrate that 1) low levels of Pb result in decreased expression of 5-HT 
within TCAs and 2) TPH expression within the DR decrease with low level Pb exposure.  
It will be exciting to further define the mechanism and determine whether these changes 
in 5-HT underlie the behavioral and cognitive impairments induced by developmental 
low-level Pb exposure.   
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Overall summary and Conclusions 
 In the current study, we investigated the effect of developmental Pb exposure on 
the transient uptake of 5-HT by LSO neurons and thalamocortical processes of early 
postnatal mice.  Our major finding is that Pb exposure delays the normal developmental 
uptake of 5-HT by LSO neurons in P4 and P8 mice.  This effect of Pb is specific for the 
transient uptake of 5-HT because Pb does not alter 5-HT immunostaining in the processes 
within the LSO that originate from the raphe nuclei.  Results from double 
immunofluorescence staining of 5-HT and SERT indicate that Pb delays the expression 
of SERT in the LSO neurons.  SERT appears to be a target for the Pb induced delay in 
transient uptake of 5-HT by LSO neurons, because Pb does not affect either synthesis or 
degradation of 5-HT in the brainstem.  In addition, Pb specifically targets SERT 
expressed by LSO neurons because it has no effect on its expression in the processes 
within the LSO.  We also found that Pb decreases 5-HT within the dorsal raphe, the 
forebrain, and the processes of thalamocortical neurons terminating within somatosensory 
cortex.  
 
Pb and the developing LSO 
Our studies reveal that neurons such as LSO neurons that transiently take up 5-HT 
during development may be specific cellular targets of Pb.  The delayed uptake of 5-HT 
by LSO neurons is correlated with the decreased expression of SYP and VMAT2 within 
the LSO, suggesting that the delayed uptake of 5-HT by LSO neurons may be one 
mechanism by which Pb impairs synaptic maturation within the LSO during the critical 
period of LSO development .  Interestingly, total brainstem levels of DA and DOPAC 
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decreased with Pb exposure, suggesting that Pb may affect the dopaminergic synapses.  
Future studies that include double-label immunofluorescence for tyrosine hydroxylase 
(TH, a marker for dopaminergic neurons) and SYP or VMAT2 are needed to determine 
whether the decreased SYP and VMAT2 staining that we observe in the Pb-treated P8 
LSO reflects a decrease in synapses of dopaminergic neurons.  The changes in GAP-43 
immunostaining further support the hypothesis that Pb disrupts axonal arborization and 
synaptic maturation in the LSO, and also suggest that GAP-43 may be a target molecule 
for Pb.   
Precise regulation of transient uptake of 5-HT by “non-serotonergic” sensory 
neurons has been shown to be critical for the proper formation of highly topographically 
organized sensory maps (Gaspar et al., 2003).  Studies suggest that this transient uptake 
of 5-HT by non-serotonergic sensory neurons is necessary to clear 5-HT away from the 
extracellular space, thereby maintaining proper extracellular concentrations of 5-HT 
during a critical period of development.  Because 5-HT functions as a neurotrophic factor 
during brain development prior to the time when it plays a role as a neurotransmitter (Luo 
et al., 2003), increased uptake of 5-HT by these non-serotonergic sensory neurons may 
limit the amount of 5-HT necessary for the development of these systems.  Our results 
showing that Pb delays the normal uptake of 5-HT by LSO neurons indicate that Pb could 
shift the extracellular concentrations of 5-HT during a critical window of LSO 
development, thereby resulting in decreased synaptic density as evidenced by decreases 
in SYP and VMAT2 imuunostaining within the LSO of P8 mice (Figure 27).  This raises 
the question:  what is the factor that mediates this 5-HT depletion induced impaired 
synaptogenesis?  One possible candidate is GAP-43.  GAP-43 is expressed early in 
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development and plays a role in axonal outgrowth and synaptic plasticity in response to 
extracellular signals (Luo et al., 203).  GAP-43 has shown to be upregulated during the 
period of barrel field formation, and is then subsequently downregulated (Maier et al., 
1999).  In GAP-43 k/o mice, thalamocortical axons fail to innervate the cortex, thus 
barrels are not formed, and forebrain levels of 5-HT and 5HIAA are decreased (Donovan 
et al., 2002).  These studies suggest that GAP-43 may be a factor that mediates the 5-HT 
induced regulation of sensory neuron development.  In the current study, we found that 
Pb decreases GAP-43 expression in the LSO at P4 and P8, the time when the highest 
levels of GAP-43 are necessary for the maturation of LSO synapses. Thus, modulation of 
GAP-43 in response to changes in extracellular 5-HT levels is one potential mechanism 
by which Pb impairs synaptic maturation within the LSO.   
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Figure 27.  Summary of the effect of Pb on the developing LSO.  LSO neuronal 
somata transiently take up 5-HT from the extracellular environment through transient 
expression of SERT during early postnatal development (P0-P7).  By P8, control (No Pb) 
LSO neurons lose their ability to take up 5-HT due to the loss of SERT.  However, Pb-
exposed LSO neurons continue to express SERT, and thus continue to take up 5-HT from 
the extracellular space.  This extended uptake of 5-HT by LSO neurons likely leads to 
decreases in the extracellular levels of 5-HT necessary for the proper maturation of the 
LSO.  This could ultimately lead to decreased arborization (in red) and synapse formation 
(decreases in SYP, VMAT2, and GAP-43) within the LSO. 
 
 
 
 
 
 
normal 
synapse 
maturation  
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Pb has a permanent effect on synpatogenesis in the LSO 
We have previously reported that Pb decreases 5-HT immunostaining in the adult 
LSO (P21) and this decrease is correlated with decreased VMAT2 and SYP expression 
(Fortune and Lurie, 2009).  In the current study, we confirmed that the decrease in 5-HT 
immunostaining observed in the adult LSO is not the result of an acute effect of Pb on 5-
HT metabolism, because Pb did not change synthesis, degradation, or re-uptake of 5-HT 
in the LSO of P21 mice.  In addition, the Pb induced decreases in SYP and VMAT2 
expression (Fortune and Lurie, 2009) were correlated with changes in the GAP-43 
staining pattern in the adult LSO.  Taken together, this data further supports the 
hypothesis that developmental Pb exposure has lasting effects on synaptic maturation 
within the LSO of adult mice (figure 28). 
 
Pb and the IC 
LSO neurons provide a major afferent input to the central nucleus of inferior 
colliculus (CNIC), contributing to the tonographically organized laminar formation 
within the IC (Thompson and Schofield, 2000).  We found that only our very low dose of 
Pb (0.01mM), increased 5-HT immunostaining in the adult CNIC (P21), but did not 
affect synthesis, degradation, or re-uptake of 5-HT in the IC.  Thus, it is likely that Pb 
acts to modulate the number of 5-HT processes within the IC and future studies will 
address this issue.  Interestingly, our low dose (0.1mM) of Pb increased VMAT2 
expression within the IC, suggesting that different doses of Pb might have two different 
effects on axonal maturation of the IC, with very low doses increasing the number of 5-
HT positive processes, and low Pb doses increasing synaptogenesis of monomaminergic 
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neurons.  To our knowledge, this is the first evidence in vivo that differing doses of Pb 
modulate different aspects of neuronal maturation and additional studies are needed to 
further elucidate this process. 
The fact that Pb increases the number of 5-HT immunoreactive processes within 
the IC, but decreases the number of these processes in the LSO suggests that Pb 
modulates process arborization differentially in the two nuclei.  Furthermore, Pb did not 
affect total expression levels of SYP in the IC, indicates that Pb subtly impairs the precise 
organization of the topographic map in the IC, instead of causing a general increase or 
decrease in the total number of synapses (Figure 28).  In addition, we did not observed IC 
neurons that transiently take up 5-HT during development in our mouse model, thus the 
changes in 5-HT and VMAT2 expression in the IC following Pb exposure could be a 
secondary effect of Pb on the LSO.  The mechanism by which Pb differentially regulates 
axon arborization and synaptogenesis in the two different nuclei remains to be 
characterized.   Investigating the effect of Pb on early postnatal development of IC will 
be necessary to fully understand how Pb regulates the synaptogenesis of the IC 
differentially compared to that of LSO.   
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Figure 28.  Summary of the effect of Pb on postnatal day 21 LSO and IC.  
Developmental Pb exposure has lasting effects on process arborization and synapse 
formation within the LSO as evidenced by decreases in 5-HT, SYP, and VMAT2 and 
altered staining patterns of GAP-43 in the adult LSO.  In the IC, a major afferent target of 
LSO, Pb increases the number of 5-HT positive processes at the very low dose 
(0.01mM), and increases VMAT2 expression with the low dose (0.1 mM).  Pb increases 
VMAT2 expression without changing SYP expression, suggesting that Pb subtly impairs 
the precise organization of the topographic map in the IC, rather than causing a general 
increase or decrease in the total number of synapses. 
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Pb and the developing somatosensory cortex 
In the somatosensory system, “non-serotonergic” thalamocortical neurons 
transiently take up 5-HT during the period of early postnatal development, and precise 
regulation of 5-HT levels has been shown to be critical for the proper formation of 
somatosensory cortical barrel fields  (BFCx) (Cases et al., 1996, 1998; Lebrand et al., 
1998; Vitalis et al., 2002).  Interestingly, early postnatal Pb exposure has been shown to 
decrease the area of the cortical barrel field (Wilson et al., 2000).  This raises the 
intriguing possibility that the Pb induced deficits in the development of the BFCx in 
rodents are associated with Pb induced alterations in the transient uptake of 5-HT by 
thalamocortical neurons.  We found that Pb indeed decreases 5-HT immunoreactivity of 
thalamocortical neurons at their axon terminals (TCAs) in the region of the BFCx during 
the early postnatal period (P4 and P8).  However, the impact of Pb on thalamocortical 
neurons and the forebrain is different to its effects on the central auditory nuclei (LSO 
and IC) and the brainstem.  In the brainstem, we found that Pb decreased 5-
HTimmunostaining in the LSO neuronal somata while having little effect on total 
brainstem levels.  In contrast, we found that Pb decreases 5-HT levels in the TCAs as 
well as in the entire forebrain and dorsal raphe.  These findings suggest that in the cortex, 
the effect of Pb is not restricted to the transient uptake of 5-HT by thalamocortical 
neurons, but may delay cortical development in general by decreasing the 5-HT levels 
available for the maturation of the forebrain (Figure 29).  In support of this, depletion of 
5-HT by PCA or DHT results in barrel fields that are either smaller in size or are 
developmentally delayed, but does not completely prevent the normal pattern of barrel 
field formation (Blue et al., 1991; Bennett-Clarke et al., 1994; Turlejski et al., 1997).  In 
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addition to the effect on barrel field formation, depletion of 5-HT has also been shown to 
affect cortical maturation by reducing both dendritic arborization and the complexity of 
the pyramidal neurons of layer III and V in the somatosensory cortex and delaying 
incorporation of interneurons into the cortical plate (Vitalis et al., 2007).  Thus, the subtle 
effect of 5-HT depletion on barrel field formation may be the result of a 5-HT induced 
delay in general brain development, rather than a direct effect of 5-HT on cortical barrel 
field formation itself (Persico et al., 2000; Luo et al., 2003; Gaspar et al., 2003).  Future 
studies, including a detailed morphometric analysis of barrel field pattern and size are 
needed to confirm that the Pb induced deficits in the development of the BFCx in rodents 
are indeed associated with the Pb induced decreases in 5-HT levels that we have found in 
the somatosensory cortex. 
 
Pb and the Dorsal Raphe 
Interestingly, Pb decreased 5-HT immunostaining in the DR of P4 mice.  This 
finding is unexpected, because Pb did not change 5-HT levels in the entire brainstem and 
the serotonergic processes within the LSO.  Because the DR is not a major source of 
serotonergic innervation in the LSO (Thompson and Thompson, 2001), and other raphe 
nuclei are localized in the brainstem fractions, it may be that decreases in 5-HT levels in 
the DR are not sufficient to result in decreases in total brainstem levels of 5-HT.  In 
contrast, the DR provides a major afferent input to the forebrain, thus the Pb-induced 
decrease in 5-HT levels in the DR are the likely explanation for the reduced 5-HT levels 
that we observe in the forebrain.  It will be interesting to examine whether Pb modulates 
5-HT levels differentially in other raphe nuclei of the brainstem.   
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Pb also increased TPH expression in the DR, indicating that this could be a 
compensatory response by DR neurons to Pb-induced decreases in 5-HT.  Because Pb 
does not alter 5-HT degradation, one potential mechanism is that Pb may inhibit the 
function of TPH resulting in an upregulation of TPH synthesis in order to compensate for 
impaired activity of the enzyme.  Further studies are necessary to fully elucidate the 
effect of Pb on TPH activity.   
To our knowledge, the current study is the first to demonstrate an effect of low-
level Pb exposure on the transient uptake of 5-HT in non-serotonergic neurons of central 
auditory and thalamocortical neurons during development.  Delaying normal transient 
accumulation of 5-HT in these neurons by Pb exposure during the critical period of 
axonal/dendritic arborization and synaptogenesis produces changes in process 
elaboration/arborization and synaptic maturation that persists into adulthood.  These 
changes may be an underlying mechanism for the behavioral and cognitive impairments 
induced by low level Pb exposure during childhood.  
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Figure 29.  Summary of the effect of Pb on postnatal day 4-8 TCA and cortex.  Pb 
decreases 5-HT levels in  in the entire forebrain and dorsal raphe and thus there is 
potentially less extracellular 5-HT available for uptake by TCAs.  These findings suggest 
that in the cortex, the effect of Pb is not restricted to the transient uptake of 5-HT by 
thalamocortical neurons, but may delay cortical development in general by decreasing the 
5-HT levels available for the maturation of the forebrain.  Pb also increases TPH 
expression in the DR, indicating that this could be a compensatory response by DR 
neurons to Pb-induced decreases in 5-HT.  Future studies are needed to determine 
whether the Pb induced decreases in the 5-HT levels in the TCAs and forebrain lead to 
impaired BFCx formation. 
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